<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0119817</article-id>
<article-id pub-id-type="publisher-id">PONE-D-14-50318</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Impact of Renal Dysfunction on Mid-Term Outcome after Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Renal Dysfunction and Transcatheter Aortic Valve Implantation</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Chi</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhao</surname>
<given-names>Zhen-Gang</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liao</surname>
<given-names>Yan-Biao</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Peng</surname>
<given-names>Yong</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Meng</surname>
<given-names>Qing-Tao</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chai</surname>
<given-names>Hua</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Qiao</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Luo</surname>
<given-names>Xiao-Lin</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Wei</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Chen</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Mao</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
<xref rid="cor001" ref-type="corresp">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Huang</surname>
<given-names>De-Jia</given-names>
</name>
<xref rid="aff001" ref-type="aff"/>
</contrib>
</contrib-group>
<aff id="aff001"><addr-line>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Cavarretta</surname>
<given-names>Elena</given-names>
</name>
<role>Academic Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Sapienza University of Rome, ITALY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: CC MC DJH. Performed the experiments: CC ZGZ YBL YP QTM HC QL XLL WL CZ. Analyzed the data: CC ZGZ. Contributed reagents/materials/analysis tools: CC ZGZ. Wrote the paper: CC.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">hmaochen@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>3</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>3</issue>
<elocation-id>e0119817</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>11</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>1</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Chen et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0119817" xlink:type="simple"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>There is conflicting evidence regarding the impact of preexisting renal dysfunction (RD) on mid-term outcomes after transcatheter aortic valve implantation (TAVI) in patients with symptomatic aortic stenosis (AS).</p>
</sec>
<sec id="sec002">
<title>Methods and results</title>
<p>Forty-seven articles representing 32,131 patients with AS undergoing a TAVI procedure were included in this systematic review and meta-analysis. Pooled analyses were performed with both univariate and multivariate models, using a fixed or random effects method when appropriate. Compared with patients with normal renal function, mid-term mortality was significantly higher in patients with preexisting RD, as defined by the author (univariate hazard ratio [HR]: 1.69; 95% confidence interval [CI]: 1.50–1.90; multivariate HR: 1.47; 95% CI: 1.17–1.84), baseline estimated glomerular filtration rate (eGFR) (univariate HR: 1.65; 95% CI: 1.47–1.86; multivariate HR: 1.46; 95% CI: 1.24–1.71), and serum creatinine (univariate HR: 1.69; 95% CI: 1.48–1.92; multivariate HR: 1.65; 95% CI: 1.36–1.99). Advanced stage of chronic kidney disease (CKD stage 3–5) was strongly related to bleeding (univariate HR in CKD stage 3: 1.30, 95% CI: 1.13–1.49; in CKD stage 4: 1.30, 95% CI: 1.04–1.62), acute kidney injure (AKI) (univariate HR in CKD stage 3: 1.28, 95% CI: 1.03–1.59; in CKD stage 4: 2.27, 95% CI: 1.74–2.96), stroke (univariate HR in CKD stage 4: 3.37, 95% CI: 1.52–7.46), and mid-term mortality (univariate HR in CKD stage 3: 1.57, 95% CI: 1.26–1.95; in CKD stage 4: 2.77, 95% CI: 2.06–3.72; in CKD stage 5: 2.64, 95% CI: 1.91–3.65) compared with CKD stage 1+2. Patients with CKD stage 4 had a higher incidence of AKI (univariate HR: 1.70, 95% CI: 1.34–2.16) and all-cause death (univariate HR: 1.60, 95% CI: 1.28–1.99) compared with those with CKD stage 3. A per unit decrease in serum creatinine was also associated with a higher mortality at mid-term follow-up (univariate HR: 1.24, 95% CI: 1.18–1.30; multivariate HR: 1.19, 95% CI: 1.08–1.30).</p>
</sec>
<sec id="sec003">
<title>Conclusions</title>
<p>Preexisting RD was associated with increased mid-term mortality after TAVI. Patients with CKD stage 4 had significantly higher incidences of peri-procedural complications and a poorer prognosis, a finding that should be factored into the clinical decision-making process regarding these patients.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>The authors have no support or funding to report.</funding-statement>
</funding-group>
<counts>
<fig-count count="8"/>
<table-count count="2"/>
<page-count count="25"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability" xlink:type="simple">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec004" sec-type="intro">
<title>Introduction</title>
<p>As a rapidly evolving procedure, transcatheter aortic valve implantation (TAVI) has been shown to be a safe and effective alternative to surgical aortic valve replacement (SAVR) in high-risk or inoperable patients with symptomatic aortic stenosis (AS) [<xref rid="pone.0119817.ref001" ref-type="bibr">1</xref>–<xref rid="pone.0119817.ref003" ref-type="bibr">3</xref>]. These aging patients frequently have a high prevalence of chronic renal dysfunction (RD), which portends a poor prognosis in those who undergo SAVR [<xref rid="pone.0119817.ref002" ref-type="bibr">2</xref>–<xref rid="pone.0119817.ref004" ref-type="bibr">4</xref>]. However, the results from studies evaluating the impact of baseline renal function on outcomes after TAVI are conflicting [<xref rid="pone.0119817.ref005" ref-type="bibr">5</xref>–<xref rid="pone.0119817.ref007" ref-type="bibr">7</xref>]. In many TAVI studies, although higher mid-term mortality were observed in patients with RD, these differences were not found to be significant by multivariate analyses [<xref rid="pone.0119817.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0119817.ref008" ref-type="bibr">8</xref>–<xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>]. In addition, the relationship between varying degrees of RD and mid-term prognosis has also not been elucidated.</p>
<p>Therefore, we conducted a meta-analysis of published studies to clarify the mid-term prognostic value of preexisting RD in patients undergoing TAVI.</p>
</sec>
<sec id="sec005" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec006">
<title>Search Strategy</title>
<p>The PubMed online database and the Cochrane library were searched for articles published from January 2002 to April 2014. The following search strategy was used: (transcatheter OR percutaneous OR transfemoral OR transapical OR transsubclavian OR transaortic OR transaxillary) AND (aortic valve) AND (implantation OR replacement) AND (risk factor OR risk assessment OR predictor OR kidney disease OR renal insufficiency OR nephropathy OR creatinine OR estimated glomerular filtration rate OR dialysis OR hemodialysis OR hemodialysis). Reference lists of comparable articles were also retrieved to seek potentially relevant citations.</p>
</sec>
<sec id="sec007">
<title>Study Selection</title>
<p>Two reviewers conducted the initial screening of titles and abstracts; full-length reports of identified studies were retrieved; and decisions were then made regarding eligibility according to pre-specified inclusion and exclusion criteria. Studies were included if they (1) reported the predictive value of the pre-procedure renal function or mortality outcomes in patients with RD compared with normal controls; (2) performed follow-ups for at least 6 months; and (3) were human studies and published in English. Studies were excluded if they were (1) abstracts, letters, editorials, or reviews and (2) duplicate publications. Studies with overlapping populations were handled by selecting the study that reported on the largest sample of patients undergoing TAVI, unless they used different definitions of RD or reported results in different analysis models.</p>
</sec>
<sec id="sec008">
<title>Data Extraction</title>
<p>Data were extracted from relevant studies using a pre-specified data collection form that included the first author, journal, year of publication, baseline characteristics, definition of RD, valve type, follow-up duration, and number of complications and deaths. Complications were defined according to the Valve Academic Research Consortium criteria [<xref rid="pone.0119817.ref011" ref-type="bibr">11</xref>], including acute kidney injure (AKI), stroke, all-cause bleeding, and major vascular complications. The outcomes from 6 months to 3 years were defined as mid-term outcomes. The incidence of all-cause mid-term mortality was the primary end point. TAVI-related complications were also the end points of interest.</p>
</sec>
<sec id="sec009">
<title>Definitions of RD</title>
<p>RD was defined as a diagnosis of chronic kidney disease (CKD), chronic renal failure, renal insufficiency, decreased estimated glomerular filtration rate (eGFR), or elevated serum creatinine level at baseline. CKD stages were classified according to baseline eGFR as follows [<xref rid="pone.0119817.ref012" ref-type="bibr">12</xref>]: ≥60 ml/min (normal or mild CKD, stage 1+2), 30–59 ml/min (moderate CKD, stage 3), 15–29 ml/min (severe CKD, stage 4), and &lt;15 ml/min or dialysis (kidney failure, stage 5). Advanced CKD was defined as CKD stage 3–5.</p>
</sec>
<sec id="sec010">
<title>Statistical Analysis</title>
<p>The hazard ratio (HR) of preexisting RD with regard to mid-term mortality after TAVI was extracted or calculated. The Generic Invers Variance method in the RevMan software, version 5.20 (The Nordic Cochrane Centre, Copenhagen, Denmark) was used for synthesis of the effect estimates. Heterogeneity was assessed by the <italic>Q</italic>-statistic and <italic>I</italic><sup>2</sup> test. The fixed effects model was selected for the analysis without significant heterogeneity (<italic>I</italic><sup>2</sup>&lt;50% and a corresponding <italic>P</italic>&gt;0.1); otherwise, the random effects model was used to obtain the combined effect estimates. Statistical significance was set at <italic>P</italic>&lt;0.05 (two-tailed). Sensitivity analyses were performed using the STATA software version 12.1 (StataCorp, College Station, TX) to test the robustness of the results and the influence of potential effect modifiers. Publication bias was assessed by graphical inspection of funnel plots, Begg’s tests, and Egger’s tests. The “Trim and Fill method” was applied if there was any evidence of publication bias [<xref rid="pone.0119817.ref013" ref-type="bibr">13</xref>].</p>
<p>The present meta-analysis was conducted and reported according to the recommendation of the MOOSE group [<xref rid="pone.0119817.ref014" ref-type="bibr">14</xref>].</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<sec id="sec012">
<title>Study Selection</title>
<p>We identified 1096 citations in the initial screening (<xref rid="pone.0119817.g001" ref-type="fig">Fig. 1</xref>). After removing duplicates and screening at the abstract level, we retrieved 286 articles for a more detailed evaluation. While 239 studies were subsequently excluded, a total of 47 full-text articles were eligible for this meta-analysis, enrolling a total of 32,131 AS patients with renal function-specific data. No significant limitations were identified for the 47 trials, 3 of which were randomized comparisons [<xref rid="pone.0119817.ref015" ref-type="bibr">15</xref>–<xref rid="pone.0119817.ref017" ref-type="bibr">17</xref>], while others were observational cohort studies [<xref rid="pone.0119817.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0119817.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0119817.ref018" ref-type="bibr">18</xref>–<xref rid="pone.0119817.ref056" ref-type="bibr">56</xref>]. Although a few studies had overlapping patient populations, they provided different outcomes according to different definitions of RD, as defined by the author [<xref rid="pone.0119817.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0119817.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0119817.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0119817.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0119817.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0119817.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0119817.ref043" ref-type="bibr">43</xref>], baseline eGFR [<xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0119817.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0119817.ref049" ref-type="bibr">49</xref>], or serum creatinine [<xref rid="pone.0119817.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0119817.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0119817.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0119817.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0119817.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0119817.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0119817.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0119817.ref056" ref-type="bibr">56</xref>]. We thus assigned these studies to different groups for either univariate or multivariate analysis.</p>
<fig id="pone.0119817.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119817.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Meta-analysis flow diagram of study selection.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119817.g001" position="float" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec013">
<title>Study and Patient Characteristics</title>
<p>The baseline features of the included patients are presented in <xref rid="pone.0119817.t001" ref-type="table">Table 1</xref>. Most studies were conducted in the general population, while a few studies performed TAVI in unique patient groups, such as octogenarians and nonagenarians [<xref rid="pone.0119817.ref043" ref-type="bibr">43</xref>], patients at very high risk (with a EuroSCORE of more than 40%) [<xref rid="pone.0119817.ref042" ref-type="bibr">42</xref>], and patients with chronic lung disease (CLD) [<xref rid="pone.0119817.ref015" ref-type="bibr">15</xref>]. Four studies elucidated the impact of detailed CKD classification on outcomes after TAVI [<xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0119817.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0119817.ref049" ref-type="bibr">49</xref>]. Patients with end-stage renal disease (ESRD) were included in 14 studies [<xref rid="pone.0119817.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0119817.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0119817.ref022" ref-type="bibr">22</xref>–<xref rid="pone.0119817.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0119817.ref038" ref-type="bibr">38</xref>–<xref rid="pone.0119817.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0119817.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0119817.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0119817.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0119817.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0119817.ref056" ref-type="bibr">56</xref>] and were excluded in 7 studies [<xref rid="pone.0119817.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0119817.ref015" ref-type="bibr">15</xref>–<xref rid="pone.0119817.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0119817.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0119817.ref049" ref-type="bibr">49</xref>]. In the remaining studies, the number of patients with ESRD was unclear. Procedural characteristics and the main outcomes after TAVI are summarized in <xref rid="pone.0119817.t002" ref-type="table">Table 2</xref>.</p>
<table-wrap id="pone.0119817.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119817.t001</object-id>
<label>Table 1</label> <caption><title>Baseline characteristics of included patients.</title></caption>
<alternatives>
<graphic id="pone.0119817.t001g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119817.t001" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th rowspan="2" align="left" colspan="1">Study</th>
<th rowspan="2" align="left" colspan="1">n</th>
<th rowspan="2" align="left" colspan="1">Male (%)</th>
<th rowspan="2" align="left" colspan="1">Age(y)</th>
<th rowspan="2" align="left" colspan="1">STS Score</th>
<th rowspan="2" align="left" colspan="1">Logistic Euroscore</th>
<th rowspan="2" align="left" colspan="1">Hypertension (%)</th>
<th rowspan="2" align="left" colspan="1">Diabetes mellitus (%)</th>
<th rowspan="2" align="left" colspan="1">Previous CAD (%)</th>
<th rowspan="2" align="left" colspan="1">Previous CE (%)</th>
<th colspan="2" align="center" rowspan="1">Renal dysfunction, n (%) / Baseline renal function</th>
<th rowspan="2" align="left" colspan="1">LVEF (%)</th>
<th rowspan="2" align="left" colspan="1">Mean AVA (cm<sup>2</sup>)</th>
<th rowspan="2" align="left" colspan="1">Mean gradient (mmHg)</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Defined</th>
<th align="left" rowspan="1" colspan="1">ESRD</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Unbehaun <italic>et al</italic>, 2011 [<xref rid="pone.0119817.ref018" ref-type="bibr">18</xref>]</td>
<td align="left" rowspan="1" colspan="1">300</td>
<td align="left" rowspan="1" colspan="1">32.3</td>
<td align="left" rowspan="1" colspan="1">79.6±8.1</td>
<td align="left" rowspan="1" colspan="1">19.1±15.5</td>
<td align="left" rowspan="1" colspan="1">38.5±19.4</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">24.0</td>
<td align="left" rowspan="1" colspan="1">59.3</td>
<td align="left" rowspan="1" colspan="1">32.7</td>
<td align="left" rowspan="1" colspan="1">Chronic Renal Failure; Baseline eGFR<xref rid="t001fn002" ref-type="table-fn"><sup>a</sup></xref> = 52.0±24.5ml/min/1.73m<sup>2</sup></td>
<td align="left" rowspan="1" colspan="1">Included</td>
<td align="left" rowspan="1" colspan="1">EF&lt;25: 9.3</td>
<td align="left" rowspan="1" colspan="1">0.7±0.2</td>
<td align="left" rowspan="1" colspan="1">48.5±14.9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tzikas <italic>et al</italic>, 2011 [<xref rid="pone.0119817.ref019" ref-type="bibr">19</xref>]</td>
<td align="left" rowspan="1" colspan="1">63</td>
<td align="left" rowspan="1" colspan="1">43</td>
<td align="left" rowspan="1" colspan="1">82(78–86)</td>
<td align="left" rowspan="1" colspan="1">5(3–8)</td>
<td align="left" rowspan="1" colspan="1">15(11–19)</td>
<td align="left" rowspan="1" colspan="1">57</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">Chronic Renal Disease/Insufficiency; n = 13(21)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">49±14</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">47±19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sinning <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref020" ref-type="bibr">20</xref>]</td>
<td align="left" rowspan="1" colspan="1">146</td>
<td align="left" rowspan="1" colspan="1">47.9</td>
<td align="left" rowspan="1" colspan="1">80.5±6.6</td>
<td align="left" rowspan="1" colspan="1">9.8±7.3</td>
<td align="left" rowspan="1" colspan="1">30.2±18.0</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">61.0</td>
<td align="left" rowspan="1" colspan="1">25.3</td>
<td align="left" rowspan="1" colspan="1">Chronic Renal Failure; n = 82(56.2)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">44.5±14.5</td>
<td align="left" rowspan="1" colspan="1">0.67±0.15</td>
<td align="left" rowspan="1" colspan="1">38.0(29.0–51.0)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Vasa-Nicotera <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref021" ref-type="bibr">21</xref>]</td>
<td align="left" rowspan="1" colspan="1">122</td>
<td align="left" rowspan="1" colspan="1">53.3</td>
<td align="left" rowspan="1" colspan="1">81.7±6.8</td>
<td align="left" rowspan="1" colspan="1">7.3±4.3</td>
<td align="left" rowspan="1" colspan="1">22.4±13.0</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">62.3</td>
<td align="left" rowspan="1" colspan="1">16.4</td>
<td align="left" rowspan="1" colspan="1">Chronic Renal Failure; n = 48(39.3)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">49.9±10.9</td>
<td align="left" rowspan="1" colspan="1">0.64±0.19</td>
<td align="left" rowspan="1" colspan="1">44.2±15.8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wendler <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref022" ref-type="bibr">22</xref>]</td>
<td align="left" rowspan="1" colspan="1">1387</td>
<td align="left" rowspan="1" colspan="1">41.5</td>
<td align="left" rowspan="1" colspan="1">80.6±7.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">27.6±16.1</td>
<td align="left" rowspan="1" colspan="1">68.9</td>
<td align="left" rowspan="1" colspan="1">28.6</td>
<td align="left" rowspan="1" colspan="1">55.9</td>
<td align="left" rowspan="1" colspan="1">15.2</td>
<td align="left" rowspan="1" colspan="1">Renal insufficiency/failure; n = 432(31.2)</td>
<td align="left" rowspan="1" colspan="1">18 patients receiving dialysis</td>
<td align="left" rowspan="1" colspan="1">EF&lt;30: 5.7</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chopard <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref023" ref-type="bibr">23</xref>]</td>
<td align="left" rowspan="1" colspan="1">3933<xref rid="t001fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">51</td>
<td align="left" rowspan="1" colspan="1">82.8±7.1</td>
<td align="left" rowspan="1" colspan="1">14.1±11.7</td>
<td align="left" rowspan="1" colspan="1">21.8±14.1</td>
<td align="left" rowspan="1" colspan="1">69</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">48</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">Chronic Kidney Disease; n = 336(9)</td>
<td align="left" rowspan="1" colspan="1">Included</td>
<td align="left" rowspan="1" colspan="1">EF&lt;30: 7.0</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Muñoz-García <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref024" ref-type="bibr">24</xref>]</td>
<td align="left" rowspan="1" colspan="1">1220<xref rid="t001fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">45.3</td>
<td align="left" rowspan="1" colspan="1">80.7±6.3</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">17.8±13</td>
<td align="left" rowspan="1" colspan="1">79.4</td>
<td align="left" rowspan="1" colspan="1">31.2</td>
<td align="left" rowspan="1" colspan="1">36.1</td>
<td align="left" rowspan="1" colspan="1">11.1</td>
<td align="left" rowspan="1" colspan="1">Oliguric Renal Failure; n = 17(1.5)</td>
<td align="left" rowspan="1" colspan="1">15 patients receiving dialysis</td>
<td align="left" rowspan="1" colspan="1">55.8±14</td>
<td align="left" rowspan="1" colspan="1">0.62±0.18</td>
<td align="left" rowspan="1" colspan="1">51.6±18</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Godino <italic>et al</italic>, 2010 [<xref rid="pone.0119817.ref025" ref-type="bibr">25</xref>]</td>
<td align="left" rowspan="1" colspan="1">137</td>
<td align="left" rowspan="1" colspan="1">53.3</td>
<td align="left" rowspan="1" colspan="1">79.5±6.7</td>
<td align="left" rowspan="1" colspan="1">7.1±4.6</td>
<td align="left" rowspan="1" colspan="1">27.4±16.7</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">29.2</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">22.6</td>
<td align="left" rowspan="1" colspan="1">eGFR&lt;60ml/min/1.73m<sup>2</sup>; n = 51(37.2)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">50.9±12.6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">52.3±17.3</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rodés-Cabau <italic>et al</italic>, 2010 [<xref rid="pone.0119817.ref005" ref-type="bibr">5</xref>]</td>
<td align="left" rowspan="1" colspan="1">339</td>
<td align="left" rowspan="1" colspan="1">44.8</td>
<td align="left" rowspan="1" colspan="1">81± 8</td>
<td align="left" rowspan="1" colspan="1">9.8±6.4</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">74.3</td>
<td align="left" rowspan="1" colspan="1">23.3</td>
<td align="left" rowspan="1" colspan="1">69.0</td>
<td align="left" rowspan="1" colspan="1">22.7</td>
<td align="left" rowspan="1" colspan="1">eGFR&lt;60ml/min/1.73m<sup>2</sup>; n = 191(56.3); Baseline creatinine = 119±83umol/l</td>
<td align="left" rowspan="1" colspan="1">10 patients receiving dialysis</td>
<td align="left" rowspan="1" colspan="1">55±14</td>
<td align="left" rowspan="1" colspan="1">0.63±0.17</td>
<td align="left" rowspan="1" colspan="1">46±17</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hayashida <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref026" ref-type="bibr">26</xref>]</td>
<td align="left" rowspan="1" colspan="1">400</td>
<td align="left" rowspan="1" colspan="1">48.5</td>
<td align="left" rowspan="1" colspan="1">83.4±6.1</td>
<td align="left" rowspan="1" colspan="1">7.9(5.1–12.3)</td>
<td align="left" rowspan="1" colspan="1">22.3(17.1–30.3)</td>
<td align="left" rowspan="1" colspan="1">69.0</td>
<td align="left" rowspan="1" colspan="1">23.0</td>
<td align="left" rowspan="1" colspan="1">59.3</td>
<td align="left" rowspan="1" colspan="1">10.3</td>
<td align="left" rowspan="1" colspan="1">eGFR&lt;60ml/min/1.73m<sup>2</sup>; n = 249(63)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">54.7±12.3</td>
<td align="left" rowspan="1" colspan="1">0.62±0.15</td>
<td align="left" rowspan="1" colspan="1">47.8±17.1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sinning <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref027" ref-type="bibr">27</xref>]</td>
<td align="left" rowspan="1" colspan="1">152</td>
<td align="left" rowspan="1" colspan="1">49.3</td>
<td align="left" rowspan="1" colspan="1">80.5±6.5</td>
<td align="left" rowspan="1" colspan="1">9.8±7.3</td>
<td align="left" rowspan="1" colspan="1">30.4±18.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">61.2</td>
<td align="left" rowspan="1" colspan="1">24.3</td>
<td align="left" rowspan="1" colspan="1">eGFR<xref rid="t002fn005" ref-type="table-fn"><sup>d</sup></xref>&lt;60ml/min/1.73m<sup>2</sup>; n = 87(57.2); Baseline eGFR = 52±21 ml/min/1.73m<sup>2</sup></td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">44.2±14.5</td>
<td align="left" rowspan="1" colspan="1">0.67±0.15</td>
<td align="left" rowspan="1" colspan="1">38.0(29.0–51.0)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nombela-Franco <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref008" ref-type="bibr">8</xref>]</td>
<td align="left" rowspan="1" colspan="1">1061</td>
<td align="left" rowspan="1" colspan="1">50.7</td>
<td align="left" rowspan="1" colspan="1">81±8</td>
<td align="left" rowspan="1" colspan="1">6.5(4.3–9.7)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">74.5</td>
<td align="left" rowspan="1" colspan="1">29.4</td>
<td align="left" rowspan="1" colspan="1">64.7</td>
<td align="left" rowspan="1" colspan="1">18.1</td>
<td align="left" rowspan="1" colspan="1">eGFR&lt;60ml/min/1.73m<sup>2</sup>; Baseline eGFR = 60.1±27.8ml/min/1.73m<sup>2</sup></td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">EF&lt;40: 22.1</td>
<td align="left" rowspan="1" colspan="1">0.66±0.19</td>
<td align="left" rowspan="1" colspan="1">43±16</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kamaga <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref028" ref-type="bibr">28</xref>]</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td align="left" rowspan="1" colspan="1">53.3</td>
<td align="left" rowspan="1" colspan="1">86±3</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">34±12</td>
<td align="left" rowspan="1" colspan="1">86.7</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">16.7</td>
<td align="left" rowspan="1" colspan="1">eGFR<xref rid="t002fn005" ref-type="table-fn"><sup>d</sup></xref>&lt;60ml/min/1.73m<sup>2</sup>; n = 18(60); Baseline eGFR = 52±17 ml/min/1.73m<sup>2</sup></td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">52±14</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dumonteil <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>]</td>
<td align="left" rowspan="1" colspan="1">942</td>
<td align="left" rowspan="1" colspan="1">53.8</td>
<td align="left" rowspan="1" colspan="1">81.0±7.0</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">20.9(12.9–28.9)</td>
<td align="left" rowspan="1" colspan="1">69.5</td>
<td align="left" rowspan="1" colspan="1">28.5</td>
<td align="left" rowspan="1" colspan="1">45.2</td>
<td align="left" rowspan="1" colspan="1">15.7</td>
<td align="left" rowspan="1" colspan="1">Chronic Kidney Disease: Mild = 329(eGFR<xref rid="t002fn005" ref-type="table-fn"><sup>d</sup></xref> = 60–89ml/min); Moderate = 399(eGFR = 30–59ml/min); Severe = 72(eGFR &lt;30ml/min)</td>
<td align="left" rowspan="1" colspan="1">33 patients receiving dialysis</td>
<td align="left" rowspan="1" colspan="1">EF&lt;35: 17</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mok <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref009" ref-type="bibr">9</xref>]</td>
<td align="left" rowspan="1" colspan="1">319</td>
<td align="left" rowspan="1" colspan="1">46.1</td>
<td align="left" rowspan="1" colspan="1">80±8</td>
<td align="left" rowspan="1" colspan="1">6.3(4.1–8.9)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">89.0</td>
<td align="left" rowspan="1" colspan="1">37.3</td>
<td align="left" rowspan="1" colspan="1">63.9</td>
<td align="left" rowspan="1" colspan="1">19.1</td>
<td align="left" rowspan="1" colspan="1">eGFR&lt;60ml/min/1.73m<sup>2</sup>; n = 192(60.2)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">54 ± 14</td>
<td align="left" rowspan="1" colspan="1">n = 192(60.2)</td>
<td align="left" rowspan="1" colspan="1">40±16</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zahn <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref030" ref-type="bibr">30</xref>]</td>
<td align="left" rowspan="1" colspan="1">1318</td>
<td align="left" rowspan="1" colspan="1">41.5</td>
<td align="left" rowspan="1" colspan="1">81.7±6.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">20.3±13.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">34.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">8.1</td>
<td align="left" rowspan="1" colspan="1">eGFR&lt;60ml/min/1.73m<sup>2</sup>; n = 798/1318(60.5)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">53.5±14.7</td>
<td align="left" rowspan="1" colspan="1">0.66±0.24</td>
<td align="left" rowspan="1" colspan="1">46. 3±21.8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Urena <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref031" ref-type="bibr">31</xref>]</td>
<td align="left" rowspan="1" colspan="1">1556</td>
<td align="left" rowspan="1" colspan="1">47.6</td>
<td align="left" rowspan="1" colspan="1">80.2±7.6</td>
<td align="left" rowspan="1" colspan="1">7.6±5.3-</td>
<td align="left" rowspan="1" colspan="1">20.5±14</td>
<td align="left" rowspan="1" colspan="1">81.4</td>
<td align="left" rowspan="1" colspan="1">31.2</td>
<td align="left" rowspan="1" colspan="1">56.4</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">eGFR&lt;60ml/min/1.73m<sup>2</sup>; n = 882 (56.7)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">55.2±13.9</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">47.3±16</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Panico <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref032" ref-type="bibr">32</xref>]</td>
<td align="left" rowspan="1" colspan="1">118</td>
<td align="left" rowspan="1" colspan="1">46.6</td>
<td align="left" rowspan="1" colspan="1">82.5±5.87</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">25.8±15.4</td>
<td align="left" rowspan="1" colspan="1">80.5</td>
<td align="left" rowspan="1" colspan="1">28.8</td>
<td align="left" rowspan="1" colspan="1">51.7</td>
<td align="left" rowspan="1" colspan="1">5.9</td>
<td align="left" rowspan="1" colspan="1">eGFR&lt;60ml/min/1.73m<sup>2</sup>; n = 53(44.9); eGFR&lt;30ml/min/1.73m<sup>2</sup>; n = 9(7.6)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">EF&lt;30: 5.9</td>
<td align="left" rowspan="1" colspan="1">0.75±0.15</td>
<td align="left" rowspan="1" colspan="1">50.9±20.6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Katsanos <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref033" ref-type="bibr">33</xref>]</td>
<td align="left" rowspan="1" colspan="1">116</td>
<td align="left" rowspan="1" colspan="1">49</td>
<td align="left" rowspan="1" colspan="1">81±8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">21.2±12.3</td>
<td align="left" rowspan="1" colspan="1">41</td>
<td align="left" rowspan="1" colspan="1">27</td>
<td align="left" rowspan="1" colspan="1">65</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Creatinine&gt;106umol/l; n = 41(35)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">54±14</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tamburino <italic>et al</italic>, 2011 [<xref rid="pone.0119817.ref034" ref-type="bibr">34</xref>]</td>
<td align="left" rowspan="1" colspan="1">663</td>
<td align="left" rowspan="1" colspan="1">44</td>
<td align="left" rowspan="1" colspan="1">81.0 ± 7.3</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">23.0±13.7</td>
<td align="left" rowspan="1" colspan="1">75.1</td>
<td align="left" rowspan="1" colspan="1">26.4</td>
<td align="left" rowspan="1" colspan="1">48.3</td>
<td align="left" rowspan="1" colspan="1">7.2</td>
<td align="left" rowspan="1" colspan="1">Creatinine&gt;133umol/l; n = 154(23.2)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">51.2±25.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">51.8±17.0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Barbanti <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref035" ref-type="bibr">35</xref>]</td>
<td align="left" rowspan="1" colspan="1">518</td>
<td align="left" rowspan="1" colspan="1">55.1</td>
<td align="left" rowspan="1" colspan="1">81.5±8.4</td>
<td align="left" rowspan="1" colspan="1">8.3±5.2</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">77.6</td>
<td align="left" rowspan="1" colspan="1">30.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">14.7</td>
<td align="left" rowspan="1" colspan="1">Creatinine&gt;177umol/l; n = 197(38)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">53.9±13.9</td>
<td align="left" rowspan="1" colspan="1">0.7±0.4</td>
<td align="left" rowspan="1" colspan="1">42.2 ±16.3</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dvir <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref015" ref-type="bibr">15</xref>]</td>
<td align="left" rowspan="1" colspan="1">1108</td>
<td align="left" rowspan="1" colspan="1">54.4</td>
<td align="left" rowspan="1" colspan="1">82.7±7.2</td>
<td align="left" rowspan="1" colspan="1">11.9±4.1</td>
<td align="left" rowspan="1" colspan="1">27.2±16.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">76.6</td>
<td align="left" rowspan="1" colspan="1">28.4</td>
<td align="left" rowspan="1" colspan="1">Creatinine&gt;177umol/l; n = 182(16.4)</td>
<td align="left" rowspan="1" colspan="1">Excluded</td>
<td align="left" rowspan="1" colspan="1">53.1±12.8</td>
<td align="left" rowspan="1" colspan="1">0.66±0.19</td>
<td align="left" rowspan="1" colspan="1">42.3±14.1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Moat <italic>et al</italic>, 2011 [<xref rid="pone.0119817.ref036" ref-type="bibr">36</xref>]</td>
<td align="left" rowspan="1" colspan="1">870</td>
<td align="left" rowspan="1" colspan="1">52.4</td>
<td align="left" rowspan="1" colspan="1">81.9±7.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">18.5(11.7–27.9)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">22.8</td>
<td align="left" rowspan="1" colspan="1">47.6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Creatinine&gt;200umol/l; n = 55(6.7)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Seiffert <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref037" ref-type="bibr">37</xref>]</td>
<td align="left" rowspan="1" colspan="1">326</td>
<td align="left" rowspan="1" colspan="1">44.5</td>
<td align="left" rowspan="1" colspan="1">80.6(79.8–81.3)</td>
<td align="left" rowspan="1" colspan="1">8.3(7.7–8.9)</td>
<td align="left" rowspan="1" colspan="1">22.7(21.2–24.2)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">61.7</td>
<td align="left" rowspan="1" colspan="1">19.3</td>
<td align="left" rowspan="1" colspan="1">Creatinine&gt;200umol/l; n = 29(8.9); Baseline creatinine = 1.5(1.3–1.6)mg/dl</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">0.7(0.7–0.7)</td>
<td align="left" rowspan="1" colspan="1">36.5(34.6–38.4)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Luçon et a<italic>l</italic>, 2014 [<xref rid="pone.0119817.ref038" ref-type="bibr">38</xref>]</td>
<td align="left" rowspan="1" colspan="1">2435</td>
<td align="left" rowspan="1" colspan="1">49.8</td>
<td align="left" rowspan="1" colspan="1">83±7</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">69</td>
<td align="left" rowspan="1" colspan="1">24.4</td>
<td align="left" rowspan="1" colspan="1">47.4</td>
<td align="left" rowspan="1" colspan="1">10.4</td>
<td align="left" rowspan="1" colspan="1">Creatinine&gt;200umol/l; n = 228(9.4)</td>
<td align="left" rowspan="1" colspan="1">63 patients receiving dialysis</td>
<td align="left" rowspan="1" colspan="1">52.8±14.6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">47.8±16.8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Heinz <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref039" ref-type="bibr">39</xref>]</td>
<td align="left" rowspan="1" colspan="1">110</td>
<td align="left" rowspan="1" colspan="1">46.4</td>
<td align="left" rowspan="1" colspan="1">83(58–97)<xref rid="t001fn006" ref-type="table-fn"><sup>e</sup></xref></td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">10(2–40)<xref rid="t001fn006" ref-type="table-fn"><sup>e</sup></xref></td>
<td align="left" rowspan="1" colspan="1">92</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">Renal impairment; n = 9(8)</td>
<td align="left" rowspan="1" colspan="1">3 patients receiving dialysis</td>
<td align="left" rowspan="1" colspan="1">50(11–73) <xref rid="t001fn006" ref-type="table-fn"><sup>e</sup></xref></td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Web <italic>et al</italic>, 2009 [<xref rid="pone.0119817.ref040" ref-type="bibr">40</xref>]</td>
<td align="left" rowspan="1" colspan="1">168</td>
<td align="left" rowspan="1" colspan="1">51.8</td>
<td align="left" rowspan="1" colspan="1">84(79–87)</td>
<td align="left" rowspan="1" colspan="1">9.1(6.3–13.0)</td>
<td align="left" rowspan="1" colspan="1">28.6(17.9–41.0)</td>
<td align="left" rowspan="1" colspan="1">64.9</td>
<td align="left" rowspan="1" colspan="1">23.2</td>
<td align="left" rowspan="1" colspan="1">67.9</td>
<td align="left" rowspan="1" colspan="1">17.9</td>
<td align="left" rowspan="1" colspan="1">Chronic Renal Failure; n = 20(11.9); Baseline creatinine = 98(81–130)umol/l</td>
<td align="left" rowspan="1" colspan="1">Included</td>
<td align="left" rowspan="1" colspan="1">EF&lt;35: 16.1</td>
<td align="left" rowspan="1" colspan="1">0.6(0.5–0.7)</td>
<td align="left" rowspan="1" colspan="1">46(34–55)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ben-Dor <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref016" ref-type="bibr">16</xref>]</td>
<td align="left" rowspan="1" colspan="1">159</td>
<td align="left" rowspan="1" colspan="1">42.7</td>
<td align="left" rowspan="1" colspan="1">84.4±5.8</td>
<td align="left" rowspan="1" colspan="1">11.8±3.9</td>
<td align="left" rowspan="1" colspan="1">42.3±21.4</td>
<td align="left" rowspan="1" colspan="1">89.3</td>
<td align="left" rowspan="1" colspan="1">32.0</td>
<td align="left" rowspan="1" colspan="1">57.2</td>
<td align="left" rowspan="1" colspan="1">27.0</td>
<td align="left" rowspan="1" colspan="1">Chronic Renal Failure; n = 64(40.2); Baseline creatinine = 1.3±1.6 mg/dl</td>
<td align="left" rowspan="1" colspan="1">Excluded</td>
<td align="left" rowspan="1" colspan="1">51.2±15.9</td>
<td align="left" rowspan="1" colspan="1">0.6±0.18</td>
<td align="left" rowspan="1" colspan="1">55.3±21.1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nuis <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref041" ref-type="bibr">41</xref>]</td>
<td align="left" rowspan="1" colspan="1">235</td>
<td align="left" rowspan="1" colspan="1">49</td>
<td align="left" rowspan="1" colspan="1">80±7</td>
<td align="left" rowspan="1" colspan="1">6.1±5.5</td>
<td align="left" rowspan="1" colspan="1">19.1±13.7</td>
<td align="left" rowspan="1" colspan="1">56</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Chronic Renal Failure; Baseline creatinine = 123±131umol/l</td>
<td align="left" rowspan="1" colspan="1">11 patients receiving dialysis</td>
<td align="left" rowspan="1" colspan="1">EF&lt;30: 14; 30–59: 35</td>
<td align="left" rowspan="1" colspan="1">0.67±0.21</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Drews <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref042" ref-type="bibr">42</xref>]</td>
<td align="left" rowspan="1" colspan="1">186</td>
<td align="left" rowspan="1" colspan="1">34.4</td>
<td align="left" rowspan="1" colspan="1">81±8</td>
<td align="left" rowspan="1" colspan="1">23±14</td>
<td align="left" rowspan="1" colspan="1">63±16</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">28.5</td>
<td align="left" rowspan="1" colspan="1">71.5</td>
<td align="left" rowspan="1" colspan="1">42.5</td>
<td align="left" rowspan="1" colspan="1">Kidney Failure; Baseline creatinine = 1.5±1.0 mg/dl</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">42±16</td>
<td align="left" rowspan="1" colspan="1">0.7±0.2</td>
<td align="left" rowspan="1" colspan="1">44±17</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yamamoto <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref043" ref-type="bibr">43</xref>]</td>
<td align="left" rowspan="1" colspan="1">2254</td>
<td align="left" rowspan="1" colspan="1">47.5</td>
<td align="left" rowspan="1" colspan="1">86.3±3.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">23.6±16.8</td>
<td align="left" rowspan="1" colspan="1">69.9<xref rid="t001fn007" ref-type="table-fn"><sup>f</sup></xref></td>
<td align="left" rowspan="1" colspan="1">21.9 <xref rid="t001fn007" ref-type="table-fn"><sup>f</sup></xref></td>
<td align="left" rowspan="1" colspan="1">48.6 <xref rid="t001fn007" ref-type="table-fn"><sup>f</sup></xref></td>
<td align="left" rowspan="1" colspan="1">9.4 <xref rid="t001fn007" ref-type="table-fn"><sup>f</sup></xref></td>
<td align="left" rowspan="1" colspan="1">Renal Insufficiency; n = 200(9.13)<xref rid="t001fn007" ref-type="table-fn"><sup>f</sup></xref></td>
<td align="left" rowspan="1" colspan="1">41 patients receiving dialysis</td>
<td align="left" rowspan="1" colspan="1">53.7±13.8</td>
<td align="left" rowspan="1" colspan="1">0.66±0.18</td>
<td align="left" rowspan="1" colspan="1">49.1±16.9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Saia <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref044" ref-type="bibr">44</xref>]</td>
<td align="left" rowspan="1" colspan="1">102</td>
<td align="left" rowspan="1" colspan="1">39.2</td>
<td align="left" rowspan="1" colspan="1">83.7±5.3</td>
<td align="left" rowspan="1" colspan="1">8.2±4.1</td>
<td align="left" rowspan="1" colspan="1">22.6±12.4</td>
<td align="left" rowspan="1" colspan="1">80.4</td>
<td align="left" rowspan="1" colspan="1">22.5</td>
<td align="left" rowspan="1" colspan="1">50</td>
<td align="left" rowspan="1" colspan="1">4.9</td>
<td align="left" rowspan="1" colspan="1">eGFR<xref rid="t001fn002" ref-type="table-fn"><sup>a</sup></xref>&lt;30ml/min/1.73m<sup>2</sup>; n = 29(28.4)</td>
<td align="left" rowspan="1" colspan="1">Excluded</td>
<td align="left" rowspan="1" colspan="1">59.9±11.6</td>
<td align="left" rowspan="1" colspan="1">0.6±0.1</td>
<td align="left" rowspan="1" colspan="1">46.0±16.7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Conrotto <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref045" ref-type="bibr">45</xref>]</td>
<td align="left" rowspan="1" colspan="1">511</td>
<td align="left" rowspan="1" colspan="1">50.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">91.2</td>
<td align="left" rowspan="1" colspan="1">29.4</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">14.3</td>
<td align="left" rowspan="1" colspan="1">eGFR&lt;30ml/min/1.73m<sup>2</sup>; n = 93(18.2)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sinning <italic>et al</italic>, 2010 [<xref rid="pone.0119817.ref006" ref-type="bibr">6</xref>]</td>
<td align="left" rowspan="1" colspan="1">77</td>
<td align="left" rowspan="1" colspan="1">48</td>
<td align="left" rowspan="1" colspan="1">80.8±6.7</td>
<td align="left" rowspan="1" colspan="1">9.3±6.1</td>
<td align="left" rowspan="1" colspan="1">31.2±17.6</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">23</td>
<td align="left" rowspan="1" colspan="1">65</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">eGFR<xref rid="t002fn005" ref-type="table-fn"><sup>d</sup></xref>&lt;60ml/min/1.73m<sup>2</sup>; n = 48(62.3); Baseline eGFR = 50.6(38.2±63.8)ml/min/1.73m<sup>2</sup></td>
<td align="left" rowspan="1" colspan="1">Excluded</td>
<td align="left" rowspan="1" colspan="1">45.3±16.8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tamburino <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref046" ref-type="bibr">46</xref>]</td>
<td align="left" rowspan="1" colspan="1">218</td>
<td align="left" rowspan="1" colspan="1">46.3</td>
<td align="left" rowspan="1" colspan="1">80.9±5.2</td>
<td align="left" rowspan="1" colspan="1">5.5±4.3</td>
<td align="left" rowspan="1" colspan="1">21.1±14.2</td>
<td align="left" rowspan="1" colspan="1">85.3</td>
<td align="left" rowspan="1" colspan="1">24.3</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">13.8</td>
<td align="left" rowspan="1" colspan="1">Creatinine&gt;133umol/l; n = 51(23.4)</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">51.1±10.6</td>
<td align="left" rowspan="1" colspan="1">0.8±0.2</td>
<td align="left" rowspan="1" colspan="1">58.2±16.8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Van Belle <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref047" ref-type="bibr">47</xref>]</td>
<td align="left" rowspan="1" colspan="1">2769</td>
<td align="left" rowspan="1" colspan="1">51.1</td>
<td align="left" rowspan="1" colspan="1">82.7±7.2</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">21.5±13.8</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">25.2</td>
<td align="left" rowspan="1" colspan="1">47.1</td>
<td align="left" rowspan="1" colspan="1">9.5</td>
<td align="left" rowspan="1" colspan="1">Creatinine&gt;200umol/l; n = 233(8.4)</td>
<td align="left" rowspan="1" colspan="1">Included</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">0.68±0.18</td>
<td align="left" rowspan="1" colspan="1">48.4±16.3</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nguyen <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref048" ref-type="bibr">48</xref>]</td>
<td align="left" rowspan="1" colspan="1">321</td>
<td align="left" rowspan="1" colspan="1">55.8</td>
<td align="left" rowspan="1" colspan="1">82.2±8.2</td>
<td align="left" rowspan="1" colspan="1">12.1±7.3</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">95.1</td>
<td align="left" rowspan="1" colspan="1">43.6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">32.1</td>
<td align="left" rowspan="1" colspan="1">Chronic Kidney Disease: Normal/Mild = 159(eGFR<xref rid="t002fn005" ref-type="table-fn"><sup>d</sup></xref>≥60ml/min); Moderate = 139(eGFR = 30–59ml/min); Severe = 23(eGFR&lt;30ml/min);</td>
<td align="left" rowspan="1" colspan="1">8 patients receiving dialysis</td>
<td align="left" rowspan="1" colspan="1">48.2±14.2</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yamamoto <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref049" ref-type="bibr">49</xref>]</td>
<td align="left" rowspan="1" colspan="1">642</td>
<td align="left" rowspan="1" colspan="1">48.1</td>
<td align="left" rowspan="1" colspan="1">83.5±6.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">22.9±12.2</td>
<td align="left" rowspan="1" colspan="1">70.6</td>
<td align="left" rowspan="1" colspan="1">22.6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">9.8</td>
<td align="left" rowspan="1" colspan="1">Chronic Kidney Disease: Stage1–2 = 218(eGFR<xref rid="t002fn005" ref-type="table-fn"><sup>d</sup></xref>≥60ml/min); Stage3a = 182(eGFR = 45–59ml/min); Stage3b = 181(eGFR = 30–44ml/min); Stage4 = 61(eGFR = 15–29ml/min)</td>
<td align="left" rowspan="1" colspan="1">Excluded</td>
<td align="left" rowspan="1" colspan="1">52.7±14.8</td>
<td align="left" rowspan="1" colspan="1">0.64±0.17</td>
<td align="left" rowspan="1" colspan="1">47.6±17.5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">D'Ascenzm <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>]</td>
<td align="left" rowspan="1" colspan="1">364</td>
<td align="left" rowspan="1" colspan="1">42.3</td>
<td align="left" rowspan="1" colspan="1">82.4±5.3</td>
<td align="left" rowspan="1" colspan="1">6.6±4.6</td>
<td align="left" rowspan="1" colspan="1">23.2±14.1</td>
<td align="left" rowspan="1" colspan="1">86.5</td>
<td align="left" rowspan="1" colspan="1">31.0</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">23.1</td>
<td align="left" rowspan="1" colspan="1">Chronic Kidney Disease; Moderate = 219(eGFR<xref rid="t001fn002" ref-type="table-fn"><sup>a</sup></xref> = 30–59ml/min); Severe = 73(eGFR = 15–29ml/min)</td>
<td align="left" rowspan="1" colspan="1">Excluded</td>
<td align="left" rowspan="1" colspan="1">52.4±11.9</td>
<td align="left" rowspan="1" colspan="1">0.62±0.18</td>
<td align="left" rowspan="1" colspan="1">53.2±17.3</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lange <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref050" ref-type="bibr">50</xref>]</td>
<td align="left" rowspan="1" colspan="1">420</td>
<td align="left" rowspan="1" colspan="1">37</td>
<td align="left" rowspan="1" colspan="1">80.3±7.1</td>
<td align="left" rowspan="1" colspan="1">6.1±4.1</td>
<td align="left" rowspan="1" colspan="1">20.17±13.0</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">55</td>
<td align="left" rowspan="1" colspan="1">13.2</td>
<td align="left" rowspan="1" colspan="1">Baseline Creatinine = 1.20±0.56 mg/dl</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">EF&gt;50: 62.4; 35–50: 22.1; &lt;35: 15.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Houthuizen <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref051" ref-type="bibr">51</xref>]</td>
<td align="left" rowspan="1" colspan="1">679</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td align="left" rowspan="1" colspan="1">81(77–85)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">16.0(10.0–25.0)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">23.6</td>
<td align="left" rowspan="1" colspan="1">47.0</td>
<td align="left" rowspan="1" colspan="1">17.7</td>
<td align="left" rowspan="1" colspan="1">Baseline Creatinine = 1.07(0.85–1.38)mg/dl</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">EF&lt;50: 28.0</td>
<td align="left" rowspan="1" colspan="1">0.7(0.6–0.8)</td>
<td align="left" rowspan="1" colspan="1">4(36–57)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gotzmann <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref052" ref-type="bibr">52</xref>]</td>
<td align="left" rowspan="1" colspan="1">198</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td align="left" rowspan="1" colspan="1">80±6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">22±16</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">52</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">Baseline Creatinine = 1.2±0.7 mg/dl</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">53±13</td>
<td align="left" rowspan="1" colspan="1">0.7±0.1</td>
<td align="left" rowspan="1" colspan="1">47±13</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Codner <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref053" ref-type="bibr">53</xref>]</td>
<td align="left" rowspan="1" colspan="1">153</td>
<td align="left" rowspan="1" colspan="1">37.9</td>
<td align="left" rowspan="1" colspan="1">82.1±6.0</td>
<td align="left" rowspan="1" colspan="1">9.2±5.3</td>
<td align="left" rowspan="1" colspan="1">22.5±13.2</td>
<td align="left" rowspan="1" colspan="1">90.2</td>
<td align="left" rowspan="1" colspan="1">29.4</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">18.3</td>
<td align="left" rowspan="1" colspan="1">Baseline eGFR = 66.7±27.3ml/min/1.73m<sup>2</sup></td>
<td align="left" rowspan="1" colspan="1">3 patients with ESRD</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">0.62±0.16</td>
<td align="left" rowspan="1" colspan="1">50.5±15.4</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sabaté<italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref054" ref-type="bibr">54</xref>]</td>
<td align="left" rowspan="1" colspan="1">1416</td>
<td align="left" rowspan="1" colspan="1">46</td>
<td align="left" rowspan="1" colspan="1">81±6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">17±11</td>
<td align="left" rowspan="1" colspan="1">78</td>
<td align="left" rowspan="1" colspan="1">34</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">Baseline Creatinine = 1.26±0.7 mg/dl</td>
<td align="left" rowspan="1" colspan="1">Unclear</td>
<td align="left" rowspan="1" colspan="1">56±13</td>
<td align="left" rowspan="1" colspan="1">0.6±0.2</td>
<td align="left" rowspan="1" colspan="1">50±15</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Linke <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref055" ref-type="bibr">55</xref>]</td>
<td align="left" rowspan="1" colspan="1">1015</td>
<td align="left" rowspan="1" colspan="1">49</td>
<td align="left" rowspan="1" colspan="1">81.1± 6.4</td>
<td align="left" rowspan="1" colspan="1">5.3(3.6–7.8)</td>
<td align="left" rowspan="1" colspan="1">16.0(10.3–25.3)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">31.3</td>
<td align="left" rowspan="1" colspan="1">57.8</td>
<td align="left" rowspan="1" colspan="1">13.1</td>
<td align="left" rowspan="1" colspan="1">Baseline Creatinine = 1.25±0.75 mg/dl; Creatinine clearance&lt;20ml/min = 148(14.9)<xref rid="t001fn008" ref-type="table-fn"><sup>g</sup></xref></td>
<td align="left" rowspan="1" colspan="1">Included</td>
<td align="left" rowspan="1" colspan="1">53.3±13.7</td>
<td align="left" rowspan="1" colspan="1">0.7±0.3</td>
<td align="left" rowspan="1" colspan="1">45.6±15.5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Unbehaun <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref056" ref-type="bibr">56</xref>]</td>
<td align="left" rowspan="1" colspan="1">730</td>
<td align="left" rowspan="1" colspan="1">39.9</td>
<td align="left" rowspan="1" colspan="1">80.1(75.3–84.4)</td>
<td align="left" rowspan="1" colspan="1">10.4(6.1–17.8)</td>
<td align="left" rowspan="1" colspan="1">28.8 (18.9–48.2)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">29.3</td>
<td align="left" rowspan="1" colspan="1">61.2</td>
<td align="left" rowspan="1" colspan="1">22.2</td>
<td align="left" rowspan="1" colspan="1">Baseline Creatinine Clearance = 53.5(38.9–69.4)ml/min</td>
<td align="left" rowspan="1" colspan="1">16 patients receiving dialysis</td>
<td align="left" rowspan="1" colspan="1">55.0(40.0–60.0)</td>
<td align="left" rowspan="1" colspan="1">0.6(0.6–0.8)</td>
<td align="left" rowspan="1" colspan="1">49.5(38.0–57.0)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kodali <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref017" ref-type="bibr">17</xref>]</td>
<td align="left" rowspan="1" colspan="1">348</td>
<td align="left" rowspan="1" colspan="1">57.8</td>
<td align="left" rowspan="1" colspan="1">83.6±6.8</td>
<td align="left" rowspan="1" colspan="1">11.8±3.3</td>
<td align="left" rowspan="1" colspan="1">29.3±16.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">74.9</td>
<td align="left" rowspan="1" colspan="1">29.3</td>
<td align="left" rowspan="1" colspan="1">Baseline Creatinine&gt;2mg/dl; n = 38(11.1)</td>
<td align="left" rowspan="1" colspan="1">Excluded</td>
<td align="left" rowspan="1" colspan="1">52.5±13.5</td>
<td align="left" rowspan="1" colspan="1">0.7±0.2</td>
<td align="left" rowspan="1" colspan="1">42.7±14.6</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Data are presented as mean±SD or median (interquartile range) as appropriate. Abbreviation used: STS: Society of Thoracic Surgeons; EuroSCORE: European system for cardiac operative risk evaluation; CAD: coronary arterial disease; CE: cerebrovascular event; ESRD: end-stage renal disease; LVEF: left ventricular ejection fraction; AVA: aortic valve area; eGFR: estimated glomerular filtration rate.</p></fn>
<fn id="t001fn002"><p>a. Calculated by Cockroft-Gault (CG) formula.</p></fn>
<fn id="t001fn003"><p>b. Mid-term outcomes available in 3597 patients.</p></fn>
<fn id="t001fn004"><p>c. Data available in 1116 patients.</p></fn>
<fn id="t001fn005"><p>d. Calculated by Modification of Diet in Renal Disease (MDRD) formula.</p></fn>
<fn id="t001fn006"><p>e. Data presented as median (minimal to max range).</p></fn>
<fn id="t001fn007"><p>f. Data available in 2190 patients.</p></fn>
<fn id="t001fn008"><p>g. Data available in 996 patients.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0119817.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119817.t002</object-id>
<label>Table 2</label> <caption><title>Procedure features and main outcomes of included studies.</title></caption>
<alternatives>
<graphic id="pone.0119817.t002g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119817.t002" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th rowspan="2" align="left" colspan="1">Study</th>
<th colspan="2" align="center" rowspan="1">Approach (%)</th>
<th rowspan="2" align="left" colspan="1">Valve type (%)</th>
<th rowspan="2" align="left" colspan="1">Follow-up</th>
<th colspan="4" align="center" rowspan="1">Peri-procedural complications</th>
<th rowspan="2" align="left" colspan="1">Death (%)</th>
<th rowspan="2" align="left" colspan="1">Cardiovascular death (%)</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">TF</th>
<th align="left" rowspan="1" colspan="1">TA</th>
<th align="left" rowspan="1" colspan="1">Renal Impairment (%)</th>
<th align="left" rowspan="1" colspan="1">Bleeding (%)</th>
<th align="left" rowspan="1" colspan="1">MVC (%)</th>
<th align="left" rowspan="1" colspan="1">Stroke (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Unbehaun <italic>et al</italic>, 2011 [<xref rid="pone.0119817.ref018" ref-type="bibr">18</xref>]</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">EV: 100</td>
<td align="left" rowspan="1" colspan="1">11.7±8.7mo</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">1.3</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">65</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tzikas <italic>et al</italic>, 2011 [<xref rid="pone.0119817.ref019" ref-type="bibr">19</xref>]</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">MCV: 100</td>
<td align="left" rowspan="1" colspan="1">383d(356–419)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">28.6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sinning <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref020" ref-type="bibr">20</xref>]</td>
<td align="left" rowspan="1" colspan="1">91.8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">MCV: 100</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI: 23.3</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">7.5</td>
<td align="left" rowspan="1" colspan="1">5.5</td>
<td align="left" rowspan="1" colspan="1">26.7</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Vasa-Nicotera <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref021" ref-type="bibr">21</xref>]</td>
<td align="left" rowspan="1" colspan="1">97.5</td>
<td align="left" rowspan="1" colspan="1">1.7</td>
<td align="left" rowspan="1" colspan="1">EV: 20.5; MCV: 79.5</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">35.2</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wendler <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref022" ref-type="bibr">22</xref>]</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">EV: 100</td>
<td align="left" rowspan="1" colspan="1">2y</td>
<td align="left" rowspan="1" colspan="1">Dialysis: 6.7</td>
<td align="left" rowspan="1" colspan="1">3.9</td>
<td align="left" rowspan="1" colspan="1">2.6</td>
<td align="left" rowspan="1" colspan="1">2.5</td>
<td align="left" rowspan="1" colspan="1">34.9</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chopard <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref023" ref-type="bibr">23</xref>]</td>
<td align="left" rowspan="1" colspan="1">73</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">EV: 66; MCV: 33</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI: 1.6</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">9.1</td>
<td align="left" rowspan="1" colspan="1">3.3</td>
<td align="left" rowspan="1" colspan="1">19.1</td>
<td align="left" rowspan="1" colspan="1">8.8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Muñoz-García <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref024" ref-type="bibr">24</xref>]</td>
<td align="left" rowspan="1" colspan="1">91.4</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">MCV: 100</td>
<td align="left" rowspan="1" colspan="1">238d(50–480)</td>
<td align="left" rowspan="1" colspan="1">AKI: 11</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">3.9</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">10.6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Godino <italic>et al</italic>, 2010 [<xref rid="pone.0119817.ref025" ref-type="bibr">25</xref>]</td>
<td align="left" rowspan="1" colspan="1">78</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">EV: 57.7; MCV: 42.3</td>
<td align="left" rowspan="1" colspan="1">6mo</td>
<td align="left" rowspan="1" colspan="1">RRT: 8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">16.8</td>
<td align="left" rowspan="1" colspan="1">0.7</td>
<td align="left" rowspan="1" colspan="1">13.1</td>
<td align="left" rowspan="1" colspan="1">5.1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rodés-Cabau <italic>et al</italic>, 2010 [<xref rid="pone.0119817.ref005" ref-type="bibr">5</xref>]</td>
<td align="left" rowspan="1" colspan="1">47.8</td>
<td align="left" rowspan="1" colspan="1">52.2</td>
<td align="left" rowspan="1" colspan="1">EV: 100</td>
<td align="left" rowspan="1" colspan="1">8mo(3–14)</td>
<td align="left" rowspan="1" colspan="1">Dialysis: 2.6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">13.3</td>
<td align="left" rowspan="1" colspan="1">2.4</td>
<td align="left" rowspan="1" colspan="1">22.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hayashida <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref026" ref-type="bibr">26</xref>]</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">EV: 86.8; MCV: 13.2</td>
<td align="left" rowspan="1" colspan="1">279d(101–607)</td>
<td align="left" rowspan="1" colspan="1">AKI: 9.0</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">8.8</td>
<td align="left" rowspan="1" colspan="1">6.5</td>
<td align="left" rowspan="1" colspan="1">27.3</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sinning <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref027" ref-type="bibr">27</xref>]</td>
<td align="left" rowspan="1" colspan="1">92.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">MCV: 100</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI: 23.0</td>
<td align="left" rowspan="1" colspan="1">9.2</td>
<td align="left" rowspan="1" colspan="1">8.6</td>
<td align="left" rowspan="1" colspan="1">5.3</td>
<td align="left" rowspan="1" colspan="1">27</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nombela-Franco <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref008" ref-type="bibr">8</xref>]</td>
<td align="left" rowspan="1" colspan="1">68.4</td>
<td align="left" rowspan="1" colspan="1">30.3</td>
<td align="left" rowspan="1" colspan="1">EV: 64; MCV: 36</td>
<td align="left" rowspan="1" colspan="1">12mo(3–23)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">2.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">37.8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kamaga <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref028" ref-type="bibr">28</xref>]</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">EV: 100</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI: 2.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">3.3</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">26.7</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dumonteil <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>]</td>
<td align="left" rowspan="1" colspan="1">84.1</td>
<td align="left" rowspan="1" colspan="1">9.3</td>
<td align="left" rowspan="1" colspan="1">EV: 46.3; MCV: 53.7</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI in CKD stage 1+2: 25.7; In CKD stage 3: 23.3; In CKD stage 4: 45.8</td>
<td align="left" rowspan="1" colspan="1">CKD stage 1+2: 42.9; CKD stage 3: 56; CKD stage 4: 52.8; CKD stage 5: 42.4</td>
<td align="left" rowspan="1" colspan="1">CKD stage 1+2: 6.1; CKD stage 3: 16.7; CKD stage 4: 11; CKD stage 5: 9.6</td>
<td align="left" rowspan="1" colspan="1">CKD stage 1+2: 1.8; CKD stage 3: 3; CKD stage 4: 4.2; CKD stage 5: 6.1</td>
<td align="left" rowspan="1" colspan="1">18.8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mok <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref009" ref-type="bibr">9</xref>]</td>
<td align="left" rowspan="1" colspan="1">39.2</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">EV: 98.7</td>
<td align="left" rowspan="1" colspan="1">12mo(7–25)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">10.7</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">3.1</td>
<td align="left" rowspan="1" colspan="1">29.5</td>
<td align="left" rowspan="1" colspan="1">14.4</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zahn <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref030" ref-type="bibr">30</xref>]</td>
<td align="left" rowspan="1" colspan="1">88</td>
<td align="left" rowspan="1" colspan="1">8.6</td>
<td align="left" rowspan="1" colspan="1">EV: 17.9; MCV: 81.5</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">2.8</td>
<td align="left" rowspan="1" colspan="1">21.8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Urena <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref031" ref-type="bibr">31</xref>]</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">22±17mo</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">23.4</td>
<td align="left" rowspan="1" colspan="1">16.3</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Panico <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref032" ref-type="bibr">32</xref>]</td>
<td align="left" rowspan="1" colspan="1">116</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">EV: 69.5; MCV: 30.5</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI: 28.9</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">5.1</td>
<td align="left" rowspan="1" colspan="1">7.6</td>
<td align="left" rowspan="1" colspan="1">17.8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Katsanos <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref033" ref-type="bibr">33</xref>]</td>
<td align="left" rowspan="1" colspan="1">41</td>
<td align="left" rowspan="1" colspan="1">59</td>
<td align="left" rowspan="1" colspan="1">EV: 100</td>
<td align="left" rowspan="1" colspan="1">25mo(13–45)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">18.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tamburino <italic>et al</italic>, 2011 [<xref rid="pone.0119817.ref034" ref-type="bibr">34</xref>]</td>
<td align="left" rowspan="1" colspan="1">90.3</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">MCV: 100</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">1.96</td>
<td align="left" rowspan="1" colspan="1">1.2</td>
<td align="left" rowspan="1" colspan="1">17.2</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Barbanti <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref035" ref-type="bibr">35</xref>]</td>
<td align="left" rowspan="1" colspan="1">66.2</td>
<td align="left" rowspan="1" colspan="1">33.2</td>
<td align="left" rowspan="1" colspan="1">EV: 93.2; MCV: 3.1</td>
<td align="left" rowspan="1" colspan="1">2y</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">22.8</td>
<td align="left" rowspan="1" colspan="1">5.8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dvir <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref015" ref-type="bibr">15</xref>]</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">23.4</td>
<td align="left" rowspan="1" colspan="1">10.2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Moat <italic>et al</italic>, 2011 [<xref rid="pone.0119817.ref036" ref-type="bibr">36</xref>]</td>
<td align="left" rowspan="1" colspan="1">68.9</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">EV: 47.1; MCV: 52.9</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">21.4</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Seiffert <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref037" ref-type="bibr">37</xref>]</td>
<td align="left" rowspan="1" colspan="1">45.7</td>
<td align="left" rowspan="1" colspan="1">52.3</td>
<td align="left" rowspan="1" colspan="1">EV: 86.2; MCV: 13.8</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI: 29.4</td>
<td align="left" rowspan="1" colspan="1">7.4</td>
<td align="left" rowspan="1" colspan="1">8.6</td>
<td align="left" rowspan="1" colspan="1">5.8</td>
<td align="left" rowspan="1" colspan="1">29.8</td>
<td align="left" rowspan="1" colspan="1">18.7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Luçon et a<italic>l</italic>, 2014 [<xref rid="pone.0119817.ref038" ref-type="bibr">38</xref>]</td>
<td align="left" rowspan="1" colspan="1">74.9</td>
<td align="left" rowspan="1" colspan="1">17.5</td>
<td align="left" rowspan="1" colspan="1">EV: 67.3; MCV: 32.7</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">1.6</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">16.4</td>
<td align="left" rowspan="1" colspan="1">10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Heinz <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref039" ref-type="bibr">39</xref>]</td>
<td align="left" rowspan="1" colspan="1">45</td>
<td align="left" rowspan="1" colspan="1">44</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI: 55.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">27</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Web <italic>et al</italic>, 2009 [<xref rid="pone.0119817.ref040" ref-type="bibr">40</xref>]</td>
<td align="left" rowspan="1" colspan="1">79.2</td>
<td align="left" rowspan="1" colspan="1">20.7</td>
<td align="left" rowspan="1" colspan="1">EV: 100</td>
<td align="left" rowspan="1" colspan="1">221d<xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref></td>
<td align="left" rowspan="1" colspan="1">AKI: 6.0; Dialysis: 1.8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">6.5</td>
<td align="left" rowspan="1" colspan="1">4.2</td>
<td align="left" rowspan="1" colspan="1">39.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ben-Dor <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref016" ref-type="bibr">16</xref>]</td>
<td align="left" rowspan="1" colspan="1">69.1</td>
<td align="left" rowspan="1" colspan="1">30.9</td>
<td align="left" rowspan="1" colspan="1">EV: 100</td>
<td align="left" rowspan="1" colspan="1">399d(167–669)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">30.8</td>
<td align="left" rowspan="1" colspan="1">7.5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nuis <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref041" ref-type="bibr">41</xref>]</td>
<td align="left" rowspan="1" colspan="1">97</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">MCV: 100</td>
<td align="left" rowspan="1" colspan="1">298d(107–688)</td>
<td align="left" rowspan="1" colspan="1">AKI: 17</td>
<td align="left" rowspan="1" colspan="1">8.9</td>
<td align="left" rowspan="1" colspan="1">10.2</td>
<td align="left" rowspan="1" colspan="1">4.6</td>
<td align="left" rowspan="1" colspan="1">31.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Drews <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref042" ref-type="bibr">42</xref>]</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">EV: 100)</td>
<td align="left" rowspan="1" colspan="1">2y</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">46</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yamamoto <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref043" ref-type="bibr">43</xref>]</td>
<td align="left" rowspan="1" colspan="1">79.06</td>
<td align="left" rowspan="1" colspan="1">16.42</td>
<td align="left" rowspan="1" colspan="1">EV: 68.5; MCV: 31.5</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">Dialysis: 1.4</td>
<td align="left" rowspan="1" colspan="1">1.2</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">2.5</td>
<td align="left" rowspan="1" colspan="1">16.9<xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Saia <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref044" ref-type="bibr">44</xref>]</td>
<td align="left" rowspan="1" colspan="1">64.7</td>
<td align="left" rowspan="1" colspan="1">23.5</td>
<td align="left" rowspan="1" colspan="1">EV: 35.3; MCV: 64.7</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI: 41.2</td>
<td align="left" rowspan="1" colspan="1">4.9</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">11.8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Conrotto <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref045" ref-type="bibr">45</xref>]</td>
<td align="left" rowspan="1" colspan="1">57.7</td>
<td align="left" rowspan="1" colspan="1">23.3</td>
<td align="left" rowspan="1" colspan="1">EV: 53.2; MCV: 46.8</td>
<td align="left" rowspan="1" colspan="1">400d(178–715)</td>
<td align="left" rowspan="1" colspan="1">AKI: 21.1</td>
<td align="left" rowspan="1" colspan="1">43.1</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">1.8</td>
<td align="left" rowspan="1" colspan="1">20.4</td>
<td align="left" rowspan="1" colspan="1">11.9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sinning <italic>et al</italic>, 2010 [<xref rid="pone.0119817.ref006" ref-type="bibr">6</xref>]</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">MCV: 100</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI: 26</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tamburino <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref046" ref-type="bibr">46</xref>]</td>
<td align="left" rowspan="1" colspan="1">97.2</td>
<td align="left" rowspan="1" colspan="1">1.8</td>
<td align="left" rowspan="1" colspan="1">EV: 11; MCV: 89</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">5.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">2.3</td>
<td align="left" rowspan="1" colspan="1">12.4</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Van Belle <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref047" ref-type="bibr">47</xref>]</td>
<td align="left" rowspan="1" colspan="1">75.3</td>
<td align="left" rowspan="1" colspan="1">17.2</td>
<td align="left" rowspan="1" colspan="1">EV: 11; MCV: 89</td>
<td align="left" rowspan="1" colspan="1">306d(178–490)</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">11.3</td>
<td align="left" rowspan="1" colspan="1">6.3</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nguyen <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref048" ref-type="bibr">48</xref>]</td>
<td align="left" rowspan="1" colspan="1">62</td>
<td align="left" rowspan="1" colspan="1">31</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">4 y</td>
<td align="left" rowspan="1" colspan="1">Dialysis: 1.9</td>
<td align="left" rowspan="1" colspan="1">CKD stage 1+2: 0.6; CKD stage 3: 1.4; CKD stage 4: 0</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">CKD stage 1+2: 1.3; CKD stage 3: 1.4; CKD stage 4: 4.4</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yamamoto <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref049" ref-type="bibr">49</xref>]</td>
<td align="left" rowspan="1" colspan="1">67.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">EV: 62.9; MCV: 37.1</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI in CKD stage 1+2: 13.3; in CKD stage 3: 17.1; in CKD stage 4: 15</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">CKD stage 1+2: 7.3; CKD stage 3: 8.3; CKD stage 4: 9.8</td>
<td align="left" rowspan="1" colspan="1">CKD stage 1+2: 1.8; CKD stage 3: 3.6; CKD stage 4: 8.2</td>
<td align="left" rowspan="1" colspan="1">25.2</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">D'Ascenzm <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>]</td>
<td align="left" rowspan="1" colspan="1">69.5</td>
<td align="left" rowspan="1" colspan="1">5.8</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">450±250d</td>
<td align="left" rowspan="1" colspan="1">AKI in CKD stage 1+2: 8; in CKD stage 3: 14; in CKD stage 4: 18</td>
<td align="left" rowspan="1" colspan="1">CKD stage 1+2: 20; CKD stage 3: 22; CKD stage 4: 33</td>
<td align="left" rowspan="1" colspan="1">CKD stage 1+2: 10; CKD stage 3: 7; CKD stage 4: 10</td>
<td align="left" rowspan="1" colspan="1">CKD stage 1+2: 1.4; CKD stage 3: 2.3; CKD stage 4: 4.1</td>
<td align="left" rowspan="1" colspan="1">17.6</td>
<td align="left" rowspan="1" colspan="1">10.2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lange <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref050" ref-type="bibr">50</xref>]</td>
<td align="left" rowspan="1" colspan="1">61</td>
<td align="left" rowspan="1" colspan="1">31</td>
<td align="left" rowspan="1" colspan="1">EV: 30.6; MCV: 68.7</td>
<td align="left" rowspan="1" colspan="1">6mo</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">18.6</td>
<td align="left" rowspan="1" colspan="1">4.5</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Houthuizen <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref051" ref-type="bibr">51</xref>]</td>
<td align="left" rowspan="1" colspan="1">68.2</td>
<td align="left" rowspan="1" colspan="1">30.3</td>
<td align="left" rowspan="1" colspan="1">EV: 43; MCV: 57</td>
<td align="left" rowspan="1" colspan="1">450d<xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref></td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">28.7</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gotzmann <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref052" ref-type="bibr">52</xref>]</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">MCV: 100</td>
<td align="left" rowspan="1" colspan="1">535±333d</td>
<td align="left" rowspan="1" colspan="1">Dialysis: 2.5</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">27.8</td>
<td align="left" rowspan="1" colspan="1">16.7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Codner <italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref053" ref-type="bibr">53</xref>]</td>
<td align="left" rowspan="1" colspan="1">73.2</td>
<td align="left" rowspan="1" colspan="1">17.6</td>
<td align="left" rowspan="1" colspan="1">EV: 40.5; MCV: 59.5</td>
<td align="left" rowspan="1" colspan="1">2y</td>
<td align="left" rowspan="1" colspan="1">AKI: 5.2</td>
<td align="left" rowspan="1" colspan="1">2.6</td>
<td align="left" rowspan="1" colspan="1">1.3</td>
<td align="left" rowspan="1" colspan="1">3.9</td>
<td align="left" rowspan="1" colspan="1">11.8</td>
<td align="left" rowspan="1" colspan="1">4.6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sabaté<italic>et al</italic>, 2013 [<xref rid="pone.0119817.ref054" ref-type="bibr">54</xref>]</td>
<td align="left" rowspan="1" colspan="1">78.7</td>
<td align="left" rowspan="1" colspan="1">21.3</td>
<td align="left" rowspan="1" colspan="1">EV: 56.9; MCV: 43.1</td>
<td align="left" rowspan="1" colspan="1">244d<xref rid="t002fn004" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">AKI<xref rid="t002fn005" ref-type="table-fn"><sup>d</sup></xref>: 1.0</td>
<td align="left" rowspan="1" colspan="1">2.4</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">2.6</td>
<td align="left" rowspan="1" colspan="1">15.9</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Linke <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref055" ref-type="bibr">55</xref>]</td>
<td align="left" rowspan="1" colspan="1">88.4</td>
<td align="left" rowspan="1" colspan="1">2.1</td>
<td align="left" rowspan="1" colspan="1">MCV: 100</td>
<td align="left" rowspan="1" colspan="1">1y</td>
<td align="left" rowspan="1" colspan="1">AKI<xref rid="t002fn005" ref-type="table-fn"><sup>d</sup></xref>: 6.0</td>
<td align="left" rowspan="1" colspan="1">13.8</td>
<td align="left" rowspan="1" colspan="1">10.9</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">17.9<xref rid="t002fn006" ref-type="table-fn"><sup>e</sup></xref></td>
<td align="left" rowspan="1" colspan="1">11.7<xref rid="t002fn006" ref-type="table-fn"><sup>e</sup></xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Unbehaun <italic>et al</italic>, 2014 [<xref rid="pone.0119817.ref056" ref-type="bibr">56</xref>]</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">EV: 100</td>
<td align="left" rowspan="1" colspan="1">1.56y(0.40–2.69)</td>
<td align="left" rowspan="1" colspan="1">AKI: 18.6; RRT: 3.0</td>
<td align="left" rowspan="1" colspan="1">9.7</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2.3</td>
<td align="left" rowspan="1" colspan="1">41.1</td>
<td align="left" rowspan="1" colspan="1">N/A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kodali <italic>et al</italic>, 2012 [<xref rid="pone.0119817.ref017" ref-type="bibr">17</xref>]</td>
<td align="left" rowspan="1" colspan="1">244</td>
<td align="left" rowspan="1" colspan="1">104</td>
<td align="left" rowspan="1" colspan="1">EV: 100</td>
<td align="left" rowspan="1" colspan="1">2y</td>
<td align="left" rowspan="1" colspan="1">AKI: 1.2</td>
<td align="left" rowspan="1" colspan="1">9.3</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">4.7</td>
<td align="left" rowspan="1" colspan="1">33.3</td>
<td align="left" rowspan="1" colspan="1">19.3</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>Data are presented as mean±SD or median (interquartile range) as appropriate. Abbreviation used: TF: trans-femoral; TA: trans-apical; MVC: major vascular complications; EV: Edwards Valve; MCV: Medtronic CoreValve; AKI: acute kidney injure; RRT: renal replacement therapy.</p></fn>
<fn id="t002fn002"><p>a. Data presented as a median.</p></fn>
<fn id="t002fn003"><p>b. Data available in 2249 patients.</p></fn>
<fn id="t002fn004"><p>c. Data presented as a mean.</p></fn>
<fn id="t002fn005"><p>d. Defined as stage 3 according to the Valve Academic Research Consortium (VARC).</p></fn>
<fn id="t002fn006"><p>e. Data available in 996 patients.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="sec014">
<title>Mid-Term Outcomes</title>
<sec id="sec015">
<title>Mid-term Mortality according to Different Definitions of RD</title>
<sec id="sec016">
<title>Defined by the Author</title>
<p>RD was defined by the author in 12 studies, in which either univariate [<xref rid="pone.0119817.ref018" ref-type="bibr">18</xref>–<xref rid="pone.0119817.ref024" ref-type="bibr">24</xref>] or multivariate [<xref rid="pone.0119817.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0119817.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0119817.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0119817.ref040" ref-type="bibr">40</xref>–<xref rid="pone.0119817.ref043" ref-type="bibr">43</xref>] analysis was performed. These studies enrolled 9769 patients, and the mid-term all-cause mortality rate was 23.6%. Patients with RD had a significantly higher risk for all-cause mortality at the mid-term follow-up (pooled univariate HR: 1.69; 95% CI: 1.50–1.90; pooled multivariate HR: 1.47; 95% CI: 1.17–1.84) compared with patients with normal renal function (<xref rid="pone.0119817.g002" ref-type="fig">Fig. 2</xref>). In the univariate model, the results were unchanged when individual studies were omitted or if the study included no more than 100 successful TAVI procedures [<xref rid="pone.0119817.ref019" ref-type="bibr">19</xref>] (pooled univariate HR: 1.67; 95% CI: 1.49–1.88). In the multivariate model, the pooled results also remained stable after removing studies in unique populations, such as patients with a EuroSCORE of more than 40% [<xref rid="pone.0119817.ref042" ref-type="bibr">42</xref>] (pooled multivariate HR: 1.45; 95% CI: 1.13–1.86), octogenarians and nonagenarians [<xref rid="pone.0119817.ref043" ref-type="bibr">43</xref>] (pooled multivariate HR: 1.51; 95% CI: 1.14–1.99), or patients without ESRD [<xref rid="pone.0119817.ref016" ref-type="bibr">16</xref>] (pooled multivariate HR: 1.42; 95% CI: 1.13–1.78).</p>
<fig id="pone.0119817.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119817.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Forest plots of mid-term mortality associated with RD.</title>
<p>A, Pooled univariate hazard ratio of patients without RD compared with patients with RD. B, Pooled multivariate hazard ratio of patients without RD compared with patients with RD. RD, renal dysfunction; CI, confidence interval; Fixed, fixed-effects model; Random, Random-effects model; IV, Generic Inverse Variance method.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119817.g002" position="float" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>Defined by eGFR</title>
<p>Thirteen studies that included a total of 6,980 patients defined RD as decreased baseline eGFR [<xref rid="pone.0119817.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0119817.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0119817.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0119817.ref025" ref-type="bibr">25</xref>–<xref rid="pone.0119817.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0119817.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0119817.ref045" ref-type="bibr">45</xref>]. The mid-term all-cause mortality rate was 24.5%. In patients with RD, mid-term mortality after TAVI was significantly increased compared with that in patients with normal renal function (pooled univariate HR: 1.65; 95% CI: 1.47–1.86; pooled multivariate HR: 1.46; 95% CI: 1.24–1.71) (<xref rid="pone.0119817.g003" ref-type="fig">Fig. 3</xref>). In the univariate analysis, the results remained unchanged after excluding the study with a small sample size [<xref rid="pone.0119817.ref028" ref-type="bibr">28</xref>] (pooled univariate HR: 1.65; 95% CI: 1.47–1.85) or the study that focused on patients with a baseline eGFR less than 30 ml/min/1.73 m<sup>2</sup> [<xref rid="pone.0119817.ref032" ref-type="bibr">32</xref>] (pooled univariate HR: 1.65; 95% CI: 1.47–1.85). Sensitivity analysis of the multivariate model also confirmed the robustness of the results after deleting 2 studies that reported the impact of severe RD (eGFR&lt;30 ml/min/1.73 m<sup>2</sup>) on the mid-term outcomes [<xref rid="pone.0119817.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0119817.ref045" ref-type="bibr">45</xref>] (pooled multivariate HR: 1.39; 95% CI: 1.18–1.64).</p>
<fig id="pone.0119817.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119817.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plots of mid-term mortality associated with RD.</title>
<p>A, Pooled univariate hazard ratio of patients without RD compared with patients with RD. B, Pooled multivariate hazard ratio of patients without RD compared with patients with RD. RD, renal dysfunction; CI, confidence interval; Fixed, fixed-effects model; IV, Generic Inverse Variance method.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119817.g003" position="float" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec018">
<title>Defined by Serum Creatinine</title>
<p>We identified 11 studies with mid-term mortality data in patients with elevated serum creatinine [<xref rid="pone.0119817.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0119817.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0119817.ref033" ref-type="bibr">33</xref>–<xref rid="pone.0119817.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0119817.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0119817.ref047" ref-type="bibr">47</xref>] (<xref rid="pone.0119817.g004" ref-type="fig">Fig. 4</xref>). The cumulative all-cause mortality rate of these 9210 patients was 17.2%. The pooled univariate HR suggested that patients with RD had a significantly higher mid-term mortality rate (pooled univariate HR: 1.69; 95% CI: 1.48–1.92) than patients with normal renal function. These results persisted when omitting individual studies or the study that reported outcomes in the CLD subgroup [<xref rid="pone.0119817.ref015" ref-type="bibr">15</xref>] (pooled univariate HR: 1.78; 95% CI: 1.54–2.05). This relationship was also observed in the multivariate model (pooled multivariate HR: 1.65; 95% CI: 1.36–1.99). After removing the relatively small study [<xref rid="pone.0119817.ref006" ref-type="bibr">6</xref>] (pooled multivariate HR: 1.58; 95% CI: 1.30–1.92) or the study that reported outcomes in the CLD subgroup [<xref rid="pone.0119817.ref015" ref-type="bibr">15</xref>] (pooled multivariate HR: 1.74; 95% CI: 1.39–2.17), the pooled results were still unchanged.</p>
<fig id="pone.0119817.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119817.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Forest plots of mid-term mortality associated with RD.</title>
<p>A, Pooled univariate hazard ratio of patients without RD compared with patients with RD. B, Pooled multivariate hazard ratio of patients without RD compared with patients with RD. RD, renal dysfunction; CI, confidence interval; Fixed, fixed-effects model; IV, Generic Inverse Variance method.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119817.g004" position="float" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec019">
<title>Association of Mid-term Outcomes with Varying Degrees of RD</title>
<p>Four studies included a detailed classification of CKD according to the baseline eGFR [<xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0119817.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0119817.ref049" ref-type="bibr">49</xref>], and an additional 4 studies reported the mid-term mortality of patients on chronic dialysis [<xref rid="pone.0119817.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0119817.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0119817.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0119817.ref038" ref-type="bibr">38</xref>].</p>
<p>Compared with patients with CKD stage 1+2, patients with advanced CKD had significantly higher incidences of all-cause bleeding (univariate HR in CKD stage 3: 1.30, 95% CI: 1.13–1.49; in CKD stage 4: 1.30, 95% CI: 1.04–1.62), post-procedural AKI (univariate HR in CKD stage 3: 1.28, 95% CI: 1.03–1.59; in CKD stage 4: 2.27, 95% CI: 1.74–2.96), and stroke (univariate HR in CKD stage 4: 3.37, 95% CI: 1.52–7.46). Major vascular complications (MVC) were without significant difference according to baseline renal function status (<xref rid="pone.0119817.g005" ref-type="fig">Fig. 5</xref>). Compared with CKD stage 3, CKD stage 4 was strongly related to a higher incidence of AKI ((univariate HR: 1.70, 95% CI: 1.34–2.16), however, this difference was not significant when focusing on bleeding or stroke (<xref rid="pone.0119817.g006" ref-type="fig">Fig. 6</xref>). Sensitivity analyses were not conducted due to the small number of studies in each groups.</p>
<fig id="pone.0119817.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119817.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Forest plots of peri-procedural complications associated with RD.</title>
<p>A, Pooled univariate hazard ratio of patients without RD compared with patients with RD for all-cause bleeding. B, Pooled univariate hazard ratio of patients without RD compared with patients with RD for major vascular complications. C, Pooled univariate hazard ratio of patients without RD compared with patients with RD for acute kidney injure. D, Pooled univariate hazard ratio of patients without RD compared with patients with RD for stroke. RD, renal dysfunction; CI, confidence interval; Fixed, fixed-effects model; IV, Generic Inverse Variance method.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119817.g005" position="float" xlink:type="simple"/>
</fig>
<fig id="pone.0119817.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119817.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Patients with CKD stage 3 versus patients with CKD stage 4 for peri-procedural complications.</title>
<p>A, Pooled univariate hazard ratio of CKD stage 3 compared with CKD stage 4 for all-cause bleeding. B, Pooled univariate hazard ratio of CKD stage 3 compared with CKD stage 4 for acute kidney injure. C, Pooled univariate hazard ratio of CKD stage 3 compared with CKD stage 4 for stroke. RD, renal dysfunction; CI, confidence interval; Fixed, fixed-effects model; IV, Generic Inverse Variance method.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119817.g006" position="float" xlink:type="simple"/>
</fig>
<p>At mid-term follow-up, advanced CKD was significantly related to a poorer prognosis compared with CKD stage 1+2 (pooled univariate HR in CKD stage 3: 1.57, 95% CI: 1.26–1.95; in CKD stage 4: 2.77, 95% CI: 2.06–3.72; in CKD stage 5: 2.64, 95% CI: 1.91–3.65). Moreover, compared with patients with CKD stage 3, mortality was significantly increased in patients with CKD stage 4 (pooled univariate HR: 1.60, 95% CI: 1.28–1.99) (<xref rid="pone.0119817.g007" ref-type="fig">Fig. 7</xref>). These results persisted after omitting individual studies in the CKD stage 5 group. Due to the small number of studies, sensitivity analyses were not performed in the other groups.</p>
<fig id="pone.0119817.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119817.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Patients with advanced stages of CKD versus patients with CKD 1+2 for mid-term mortality.</title>
<p>A, Pooled univariate hazard ratio of advanced stages of CKD compared with CKD stage 1+2 for all-cause mid-term mortality. B, Pooled multivariate hazard ratio of advanced stages of CKD compared with CKD stage 1+2 for all-cause mid-term mortality. RD, renal dysfunction; CI, confidence interval; Random, Random-effects model; Fixed, fixed-effects model; IV, Generic Inverse Variance method.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119817.g007" position="float" xlink:type="simple"/>
</fig>
<p>A total of 9 studies that included 5,266 patients were eligible for the pooled analysis of baseline serum creatinine (for each increase of 1 mg/dl) with respect to mid-term outcomes [<xref rid="pone.0119817.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0119817.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0119817.ref050" ref-type="bibr">50</xref>–<xref rid="pone.0119817.ref056" ref-type="bibr">56</xref>] (<xref rid="pone.0119817.g008" ref-type="fig">Fig. 8</xref>). The cumulative mortality after TAVI was 24.1%. Each 1 mg/dl increase in serum creatinine significantly raised the mid-term all-cause mortality rate (pooled univariate HR: 1.24, 95% CI: 1.18–1.30; pooled multivariate HR: 1.19, 95% CI: 1.08–1.30). The pooled results remained stable when individual studies in the univariate model were omitted and also persisted in the multivariate analysis after removing the study that excluded patients with ESRD [<xref rid="pone.0119817.ref018" ref-type="bibr">18</xref>] (pooled multivariate HR: 1.24, 95% CI: 1.16–1.32).</p>
<fig id="pone.0119817.g008" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119817.g008</object-id>
<label>Fig 8</label>
<caption>
<title>Forest plots of mid-term mortality associated with RD.</title>
<p>A, Pooled univariate hazard ratio of patients without RD compared with patients with RD for all-cause mid-term mortality. B, Pooled multivariate hazard ratio of patients without RD compared with patients with RD for all-cause mid-term mortality. RD, renal dysfunction; CI, confidence interval; Fixed, fixed-effects model; Random, Random-effects model; IV, Generic Inverse Variance method.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119817.g008" position="float" xlink:type="simple"/>
</fig>
<p>The study by Le Ven et al [<xref rid="pone.0119817.ref057" ref-type="bibr">57</xref>] reported a similar finding with regard to baseline eGFR; specifically, each 10 ml/min decrease was found to be associated with a significantly higher risk of all-cause mortality after TAVI (univariate HR: 1.14, 95% CI: 1.07–1.22; multivariate HR: 1.14, 95% CI: 1.07–1.22).</p>
</sec>
</sec>
<sec id="sec020">
<title>Publication Bias</title>
<p>Although a subtle publication bias was observed in the funnel plot inspection comparing patients with RD (defined as decreased eGFR) with patients with normal renal function in the univariate model, the pooled estimates remained significant after implementing the “Trim and Fill” method. In the rest of the analyses, funnel plots, Begg’s test and Egger’s test did not provide clear evidence for publication bias (<xref rid="pone.0119817.s002" ref-type="supplementary-material">S1</xref>–<xref rid="pone.0119817.s006" ref-type="supplementary-material">S5</xref> Figs).</p>
</sec>
<sec id="sec021" sec-type="conclusions">
<title>Discussion</title>
<p>The present study is the first to conduct pooled analyses (using both univariate and multivariate models) of the mid-term prognostic value of RD after TAVI. Preexisting RD, despite different definitions, was found to be associated with significantly increased mid-term mortality. Although it has been clearly demonstrated that aging patients with symptomatic AS have a high prevalence of RD, only a few TAVI studies have treated RD as a component of the primary study question, and the results have been conflicting [<xref rid="pone.0119817.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0119817.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0119817.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0119817.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0119817.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0119817.ref058" ref-type="bibr">58</xref>]. By conducting this meta-analysis, we have clearly shown a correlation between mid-term outcome and baseline renal function, as reflected by either baseline eGFR or serum creatinine.</p>
<p>Varying degrees of RD, as classified by advanced stages of CKD, were associated with significantly higher incidences of bleeding, AKI, and mid-term mortality after TAVI. Post-procedural stroke occurred more frequently in patients with CKD stage 4 compared with CKD 1+2. These findings were in line with previous TAVI studies focusing on the peri-procedural complications [<xref rid="pone.0119817.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0119817.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0119817.ref059" ref-type="bibr">59</xref>]. However, differences about the incidence of MVC were not significant in our study. At mid-term follow-up, patients with CKD stage 4 were noted to have a poorer prognosis compared with patients with CKD stage 3. This graded association was further confirmed when considering baseline serum creatinine (for each 1 mg/mL decrease), which was also strongly related to increased mid-term mortality. In previous studies, advanced stages of CKD have been shown to be independent risk factors in patients undergoing TAVI [<xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0119817.ref049" ref-type="bibr">49</xref>]. However, no stepwise increased adverse events was observed in patients with more severe CKD [<xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>]. By pooling estimate effects from these individual studies, we found that patients with CKD stage 4 had significantly higher incidence of AKI and mortality rates compared with those with CKD stage 3. Because patients with ESRD have been excluded from many TAVI studies, only sparse data exist on the prognostic value of CKD stage 5 [<xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0119817.ref060" ref-type="bibr">60</xref>]. In the present study, pre-procedural chronic dialysis was also shown to be a strong risk factor for mid-term mortality after TAVI.</p>
<p>The presence of RD is an important factor contributing to poorer outcomes in patients undergoing TAVI. This phenomenon can be explained by several aspects. (1) Patients with RD were older, were frailer, and presented with a significantly higher Logistic Euroscore in previous studies [<xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0119817.ref049" ref-type="bibr">49</xref>]. In view of these data, RD may serve as a marker of unbalanced baseline risk profiles. Patients with RD frequently have a higher burden of severe morbidities, which may adversely affect their survival after TAVI. (2) RD modifies the natural history of AS, presumably through a pathophysiological mechanism that promotes calcium deposition on aortic leaflets, thereby worsening aortic stenosis and reducing cardiac output [<xref rid="pone.0119817.ref061" ref-type="bibr">61</xref>]. Severe AS with decreased flow to important organs is responsible for the onset of severe complications, which subsequently increase the mortality after TAVI [<xref rid="pone.0119817.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0119817.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0119817.ref062" ref-type="bibr">62</xref>]. RD was also found to be associated with disorders of primary hemostasis, in particular platelet malfunctions [<xref rid="pone.0119817.ref063" ref-type="bibr">63</xref>], which played an important role in the occurrence of peri-procedural bleeding and subsequently increased mortality [<xref rid="pone.0119817.ref059" ref-type="bibr">59</xref>]. (3) It is well known that one of the advantages of TAVI is the avoidance of cardiopulmonary bypass, which is one of the most important risk factors for post-procedural AKI [<xref rid="pone.0119817.ref064" ref-type="bibr">64</xref>]. However, the incidence of contrast-induced nephropathy (CIN) could conceivably increase as a result of the extensive use of contrast medium and multiple injections [<xref rid="pone.0119817.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0119817.ref066" ref-type="bibr">66</xref>]. Although few studies have identified a significant association between contrast agents and AKI in the general population [<xref rid="pone.0119817.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0119817.ref068" ref-type="bibr">68</xref>], when focusing on patients with RD, the incidence of CIN was found to be significantly enhanced. Among patients with CKD, the occurrence of CIN was strongly associated with a higher 60-day mortality [<xref rid="pone.0119817.ref069" ref-type="bibr">69</xref>], indicating that the nephrotoxic mechanisms of CIN were one of the major issues contributing to the mid-term mortality in such patients.</p>
<p>In patients with more severe kidney failure, a higher Logistic Euroscore and lower ejection fraction were more frequent [<xref rid="pone.0119817.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>]. Moreover, the incidence of post-procedural renal impairment was also significantly higher in patients with more severe RD, despite using a smaller dose of contrast medium [<xref rid="pone.0119817.ref029" ref-type="bibr">29</xref>]. These results could explain the graded association between the severity of RD and the stepwise increase in mortality after TAVI.</p>
<p>In view of these data, RD appears to be not only a marker of illness severity, but it also represents a risk factor for mid-term prognosis. Therefore, rigorous risk assessment, preventive therapies for bleeding and stroke, and timely detection of AKI would be crucial interventions that would improve the mid-term mortality after TAVI. Our study revealed higher incidence of peri-procedural complications and poorer outcomes in patients with CKD stage 4. However, this result also raises questions regarding whether these high-risk patients actually benefit from a TAVI procedure and which patients are at the highest risk of mid-term mortality.</p>
</sec>
<sec id="sec022">
<title>Limitations</title>
<p>Several limitations exist in our study. (1) Because the present meta-analysis was based only on published studies, the possibility of potential publication bias cannot be completely ruled out. (2) Although careful screening was conducted, the possibility of overlapping study populations could result in similar estimates. (3) Our meta-analysis was not conducted at the patient level, and only 5 studies treated RD as the primary study question. Even though the renal function-specific baseline characteristics were not available, the effects of comorbidities could not be assessed. (4) The adjusted prognostic value of different degrees of RD on the mid-term mortality after TAVI was not assessed due to the scarcity of study data. (5) Most included studies calculated eGFR using the MDRD equation, which is affected by the considerable decline in muscle mass with age, severe cardiovascular disease, drugs, and diet, making it difficult to reflect the actual renal clearance in the cohort of elderly patients.</p>
</sec>
<sec id="sec023" sec-type="conclusions">
<title>Conclusions</title>
<p>Preexisting RD, despite different definitions, was associated with significantly increased mid-term mortality after TAVI. Varying degrees of RD were strongly associated with a stepwise increase in mid-term mortality rates. Given that patients with CKD stage 4 had a higher incidence of peri-procedural complications and a poorer prognosis, TAVI in such patients may present a significant challenge.</p>
</sec>
<sec id="sec024">
<title>Supporting Information</title>
<supplementary-material id="pone.0119817.s001" xlink:href="info:doi/10.1371/journal.pone.0119817.s001" mimetype="application/msword" position="float" xlink:type="simple">
<label>S1 Checklist</label>
<caption>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0119817.s002" xlink:href="info:doi/10.1371/journal.pone.0119817.s002" mimetype="image/tiff" position="float" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Funnel plots of comparison between RD (defined by the author) and normal renal function for mid-term mortality.</title>
<p>A, Comparison in univariable model (Begg’s test: P = 0.23; Egger’s test: P = 0.208; Trim and Fill Analysis not performed). B, Comparison in multivariable model. (Begg’s test: P = 0.548; Egger’s test: P = 0.215; Trim and Fill Analysis not performed).</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0119817.s003" xlink:href="info:doi/10.1371/journal.pone.0119817.s003" mimetype="image/tiff" position="float" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Funnel plots of comparison between RD (defined as decreased eGFR) and normal renal function for mid-term mortality.</title>
<p>A, Comparison in univariable model. (Begg’s test: P = 0.119; Egger’s test: P = 0.129; Trim and Fill Analysis not performed). B, Comparison in multivariable model. (Begg’s test: P = 0.133; Egger’s test: P = 0.06; Trim and Fill Analysis: Pooled estimate = 0.306, P&lt;0.001).</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0119817.s004" xlink:href="info:doi/10.1371/journal.pone.0119817.s004" mimetype="image/tiff" position="float" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Funnel plots of comparison between RD (defined as increased Serum creatinine) and normal renal function for mid-term mortality.</title>
<p>A, Comparison in univariable model. (Begg’s test: P = 0.711; Egger’s test: P = 0.711; Trim and Fill Analysis not performed). B, Comparison in multivariable model. (Begg’s test: P = 0.133; Egger’s test: P = 0.086; Trim and Fill Analysis: Pooled estimate = 0.436, P&lt;0.001).</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0119817.s005" xlink:href="info:doi/10.1371/journal.pone.0119817.s005" mimetype="image/tiff" position="float" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Funnel plots of comparison between CKD stage 5 and CKD stage 1+2 for mid-term mortality.</title>
<p>Begg’s test: P = 0.806; Egger’s test: P = 0.841; Trim and Fill Analysis not performed.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0119817.s006" xlink:href="info:doi/10.1371/journal.pone.0119817.s006" mimetype="image/tiff" position="float" xlink:type="simple">
<label>S5 Fig</label>
<caption>
<title>Funnel plots for the impact of baseline serum creatinine (for each increase of 1 mg/dl) on the mid-term mortality.</title>
<p>A, Preformed in univariable model. (Begg’s test: P = 0.902; Egger’s test: P = 0.430; Trim and Fill Analysis not performed). B, Preformed in multivariable model. (Begg’s test: P = 0.764; Egger’s test: P = 0.507; Trim and Fill Analysis not performed).</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0119817.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Leon</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Mack</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Moses</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Svensson</surname> <given-names>LG</given-names></name>, <etal>et al</etal>. <article-title>Transcatheter versus surgical aortic-valve replacement in high-risk patients</article-title>. <source>N Engl J Med</source>. <year>2011</year>;<volume>364</volume>: <fpage>2187</fpage>–<lpage>98</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1103510" xlink:type="simple">10.1056/NEJMoa1103510</ext-link></comment> <object-id pub-id-type="pmid">21639811</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leon</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Mack</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Moses</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Svensson</surname> <given-names>LG</given-names></name>, <etal>et al</etal>. <article-title>Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery</article-title>. <source>N Engl J Med</source>. <year>2010</year>;<volume>363</volume>: <fpage>1597</fpage>–<lpage>607</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1008232" xlink:type="simple">10.1056/NEJMoa1008232</ext-link></comment> <object-id pub-id-type="pmid">20961243</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Makkar</surname> <given-names>RR</given-names></name>, <name name-style="western"><surname>Fontana</surname> <given-names>GP</given-names></name>, <name name-style="western"><surname>Jilaihawi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kapadia</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Pichard</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Douglas</surname> <given-names>PS</given-names></name>, <etal>et al</etal>. <article-title>Transcatheter aortic-valve replacement for inoperable severe aortic stenosis</article-title>. <source>N Engl J Med</source>. <year>2012</year>;<volume>366</volume>: <fpage>1696</fpage>–<lpage>704</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1202277" xlink:type="simple">10.1056/NEJMoa1202277</ext-link></comment> <object-id pub-id-type="pmid">22443478</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thourani</surname> <given-names>VH</given-names></name>, <name name-style="western"><surname>Keeling</surname> <given-names>WB</given-names></name>, <name name-style="western"><surname>Sarin</surname> <given-names>EL</given-names></name>, <name name-style="western"><surname>Guyton</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Kilgo</surname> <given-names>PD</given-names></name>, <name name-style="western"><surname>Dara</surname> <given-names>AB</given-names></name>, <etal>et al</etal>. <article-title>Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement</article-title>. <source>Ann Thorac Surg</source>. <year>2011</year>;<volume>91</volume>: <fpage>1798</fpage>–<lpage>806</lpage>; discussion 806–7. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.athoracsur.2011.02.015" xlink:type="simple">10.1016/j.athoracsur.2011.02.015</ext-link></comment> <object-id pub-id-type="pmid">21536247</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rodes-Cabau</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Webb</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Cheung</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ye</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Dumont</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Feindel</surname> <given-names>CM</given-names></name>, <etal>et al</etal>. <article-title>Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience</article-title>. <source>J Am Coll Cardiol</source>. <year>2010</year>;<volume>55</volume>: <fpage>1080</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2009.12.014" xlink:type="simple">10.1016/j.jacc.2009.12.014</ext-link></comment> <object-id pub-id-type="pmid">20096533</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sinning</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Ghanem</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Steinhauser</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Adenauer</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Hammerstingl</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Nickenig</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2010</year>;<volume>3</volume>: <fpage>1141</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jcin.2010.09.009" xlink:type="simple">10.1016/j.jcin.2010.09.009</ext-link></comment> <object-id pub-id-type="pmid">21087750</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wessely</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rau</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lange</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Kehl</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Renz</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Schonermarck</surname> <given-names>U</given-names></name>, <etal>et al</etal>. <article-title>Chronic kidney disease is not associated with a higher risk for mortality or acute kidney injury in transcatheter aortic valve implantation</article-title>. <source>Nephrol Dial Transplant</source>. <year>2012</year>;<volume>27</volume>: <fpage>3502</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/ndt/gfs102" xlink:type="simple">10.1093/ndt/gfs102</ext-link></comment> <object-id pub-id-type="pmid">22535634</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nombela-Franco</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Webb</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>de Jaegere</surname> <given-names>PP</given-names></name>, <name name-style="western"><surname>Toggweiler</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nuis</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Dager</surname> <given-names>AE</given-names></name>, <etal>et al</etal>. <article-title>Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation</article-title>. <source>Circulation</source>. <year>2012</year>;<volume>126</volume>: <fpage>3041</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCULATIONAHA.112.110981" xlink:type="simple">10.1161/CIRCULATIONAHA.112.110981</ext-link></comment> <object-id pub-id-type="pmid">23149669</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mok</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nombela-Franco</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Dumont</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Urena</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>DeLarochelliere</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Doyle</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2013</year>;<volume>6</volume>: <fpage>1072</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jcin.2013.06.008" xlink:type="simple">10.1016/j.jcin.2013.06.008</ext-link></comment> <object-id pub-id-type="pmid">24156967</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>D'Ascenzo</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Moretti</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Salizzoni</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bollati</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>D'Amico</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ballocca</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study</article-title>. <source>Int J Cardiol</source>. <year>2013</year>;<volume>167</volume>: <fpage>1514</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijcard.2012.04.161" xlink:type="simple">10.1016/j.ijcard.2012.04.161</ext-link></comment> <object-id pub-id-type="pmid">22726400</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leon</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Piazza</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Nikolsky</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Blackstone</surname> <given-names>EH</given-names></name>, <name name-style="western"><surname>Cutlip</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Kappetein</surname> <given-names>AP</given-names></name>, <etal>et al</etal>. <article-title>Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium</article-title>. <source>Eur Heart J</source>. <year>2011</year>;<volume>32</volume>: <fpage>205</fpage>–<lpage>17</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/eurheartj/ehq406" xlink:type="simple">10.1093/eurheartj/ehq406</ext-link></comment> <object-id pub-id-type="pmid">21216739</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levey</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Eckardt</surname> <given-names>KU</given-names></name>, <name name-style="western"><surname>Tsukamoto</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Levin</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Coresh</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Rossert</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)</article-title>. <source>Kidney Int</source>. <year>2005</year>;<volume>67</volume>: <fpage>2089</fpage>–<lpage>100</lpage>. <object-id pub-id-type="pmid">15882252</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duval</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tweedie</surname> <given-names>R</given-names></name>. <article-title>Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis</article-title>. <source>Biometrics</source>. <year>2000</year>;<volume>56</volume>: <fpage>455</fpage>–<lpage>63</lpage>. <object-id pub-id-type="pmid">10877304</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stroup</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>Berlin</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Morton</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Olkin</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Williamson</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Rennie</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group</article-title>. <source>Jama</source>. <year>2000</year>;<volume>283</volume>: <fpage>2008</fpage>–<lpage>12</lpage>. <object-id pub-id-type="pmid">10789670</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dvir</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Waksman</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Barbash</surname> <given-names>IM</given-names></name>, <name name-style="western"><surname>Kodali</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Svensson</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Tuzcu</surname> <given-names>EM</given-names></name>, <etal>et al</etal>. <article-title>Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve)</article-title>. <source>J Am Coll Cardiol</source>. <year>2014</year>;<volume>63</volume>: <fpage>269</fpage>–<lpage>79</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2013.09.024" xlink:type="simple">10.1016/j.jacc.2013.09.024</ext-link></comment> <object-id pub-id-type="pmid">24140659</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ben-Dor</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Dvir</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Barbash</surname> <given-names>IM</given-names></name>, <name name-style="western"><surname>Okubagzi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Torguson</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Xue</surname> <given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>Outcomes of patients with severe aortic stenosis at high surgical risk evaluated in a trial of transcatheter aortic valve implantation</article-title>. <source>Am J Cardiol</source>. <year>2012</year>;<volume>110</volume>: <fpage>1008</fpage>–<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2012.05.034" xlink:type="simple">10.1016/j.amjcard.2012.05.034</ext-link></comment> <object-id pub-id-type="pmid">22721576</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kodali</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Svensson</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Webb</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Makkar</surname> <given-names>RR</given-names></name>, <etal>et al</etal>. <article-title>Two-year outcomes after transcatheter or surgical aortic-valve replacement</article-title>. <source>N Engl J Med</source>. <year>2012</year>;<volume>366</volume>: <fpage>1686</fpage>–<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1200384" xlink:type="simple">10.1056/NEJMoa1200384</ext-link></comment> <object-id pub-id-type="pmid">22443479</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Unbehaun</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pasic</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Drews</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Dreysse</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kukucka</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hetzer</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Analysis of survival in 300 high-risk patients up to 2.5 years after transapical aortic valve implantation</article-title>. <source>Ann Thorac Surg</source>. <year>2011</year>;<volume>92</volume>: <fpage>1315</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.athoracsur.2011.05.077" xlink:type="simple">10.1016/j.athoracsur.2011.05.077</ext-link></comment> <object-id pub-id-type="pmid">21958779</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tzikas</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Geleijnse</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Van Mieghem</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Schultz</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Nuis</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>van Dalen</surname> <given-names>BM</given-names></name>, <etal>et al</etal>. <article-title>Left ventricular mass regression one year after transcatheter aortic valve implantation</article-title>. <source>Ann Thorac Surg</source>. <year>2011</year>;<volume>91</volume>: <fpage>685</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.athoracsur.2010.09.037" xlink:type="simple">10.1016/j.athoracsur.2010.09.037</ext-link></comment> <object-id pub-id-type="pmid">21352980</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sinning</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Hammerstingl</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Vasa-Nicotera</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Adenauer</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Lema Cachiguango</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Scheer</surname> <given-names>AC</given-names></name>, <etal>et al</etal>. <article-title>Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation</article-title>. <source>J Am Coll Cardiol</source>. <year>2012</year>;<volume>59</volume>: <fpage>1134</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2011.11.048" xlink:type="simple">10.1016/j.jacc.2011.11.048</ext-link></comment> <object-id pub-id-type="pmid">22440213</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vasa-Nicotera</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sinning</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Chin</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Lim</surname> <given-names>TK</given-names></name>, <name name-style="western"><surname>Spyt</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Jilaihawi</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2012</year>;<volume>5</volume>: <fpage>858</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jcin.2012.04.011" xlink:type="simple">10.1016/j.jcin.2012.04.011</ext-link></comment> <object-id pub-id-type="pmid">22917458</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wendler</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Walther</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Schroefel</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Lange</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Treede</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Fusari</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Transapical aortic valve implantation: mid-term outcome from the SOURCE registry</article-title>. <source>Eur J Cardiothorac Surg</source>. <year>2013</year>;<volume>43</volume>: <fpage>505</fpage>–<lpage>11</lpage>; discussion 11–2. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/ejcts/ezs297" xlink:type="simple">10.1093/ejcts/ezs297</ext-link></comment> <object-id pub-id-type="pmid">22648920</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chopard</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Meneveau</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Chocron</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gilard</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Laskar</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Eltchaninoff</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Impact of chronic obstructive pulmonary disease on Valve Academic Research Consortium-defined outcomes after transcatheter aortic valve implantation (from the FRANCE 2 Registry)</article-title>. <source>Am J Cardiol</source>. <year>2014</year>;<volume>113</volume>: <fpage>1543</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2014.01.432" xlink:type="simple">10.1016/j.amjcard.2014.01.432</ext-link></comment> <object-id pub-id-type="pmid">24630784</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Munoz-Garcia</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>del Valle</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Trillo-Nouche</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Elizaga</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gimeno</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Hernandez-Antolin</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results</article-title>. <source>Int J Cardiol</source>. <year>2013</year>;<volume>169</volume>: <fpage>359</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijcard.2013.09.006" xlink:type="simple">10.1016/j.ijcard.2013.09.006</ext-link></comment> <object-id pub-id-type="pmid">24128731</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Godino</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Maisano</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Montorfano</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Latib</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chieffo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Michev</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2010</year>;<volume>3</volume>: <fpage>1110</fpage>–<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jcin.2010.09.012" xlink:type="simple">10.1016/j.jcin.2010.09.012</ext-link></comment> <object-id pub-id-type="pmid">21087745</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayashida</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Lefevre</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Chevalier</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hovasse</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Romano</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Garot</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Impact of post-procedural aortic regurgitation on mortality after transcatheter aortic valve implantation</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2012</year>;<volume>5</volume>: <fpage>1247</fpage>–<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jcin.2012.09.003" xlink:type="simple">10.1016/j.jcin.2012.09.003</ext-link></comment> <object-id pub-id-type="pmid">23257373</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sinning</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Scheer</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Adenauer</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Ghanem</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hammerstingl</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Schueler</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation</article-title>. <source>Eur Heart J</source>. <year>2012</year>;<volume>33</volume>: <fpage>1459</fpage>–<lpage>68</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/eurheartj/ehs002" xlink:type="simple">10.1093/eurheartj/ehs002</ext-link></comment> <object-id pub-id-type="pmid">22285582</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kamga</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Boland</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Cornette</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Beeckmans</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>De Meester</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Chenu</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Impact of frailty scores on outcome of octogenarian patients undergoing transcatheter aortic valve implantation</article-title>. <source>Acta Cardiol</source>. <year>2013</year>;<volume>68</volume>: <fpage>599</fpage>–<lpage>606</lpage>. <object-id pub-id-type="pmid">24579438</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dumonteil</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>van der Boon</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Tchetche</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Chieffo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Van Mieghem</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Marcheix</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Impact of preoperative chronic kidney disease on short- and long-term outcomes after transcatheter aortic valve implantation: a Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC-Plus) initiative substudy</article-title>. <source>Am Heart J</source>. <year>2013</year>;<volume>165</volume>: <fpage>752</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ahj.2012.12.013" xlink:type="simple">10.1016/j.ahj.2012.12.013</ext-link></comment> <object-id pub-id-type="pmid">23622912</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zahn</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Gerckens</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Linke</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sievert</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kahlert</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hambrecht</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis</article-title>. <source>Am J Cardiol</source>. <year>2013</year>;<volume>112</volume>: <fpage>272</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2013.03.024" xlink:type="simple">10.1016/j.amjcard.2013.03.024</ext-link></comment> <object-id pub-id-type="pmid">23578349</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Urena</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Webb</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Tamburino</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Munoz-Garcia</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Cheema</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dager</surname> <given-names>AE</given-names></name>, <etal>et al</etal>. <article-title>Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function</article-title>. <source>Circulation</source>. <year>2014</year>;<volume>129</volume>: <fpage>1233</fpage>–<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCULATIONAHA.113.005479" xlink:type="simple">10.1161/CIRCULATIONAHA.113.005479</ext-link></comment> <object-id pub-id-type="pmid">24370552</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Panico</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pagnotta</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mennuni</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Corrada</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Barbaro</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Rossi</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Predictors of mortality in patients undergoing percutaneous aortic valve implantation</article-title>. <source>Minerva Cardioangiol</source>. <year>2012</year>;<volume>60</volume>: <fpage>561</fpage>–<lpage>71</lpage>. <object-id pub-id-type="pmid">23147434</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Katsanos</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yiu</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Clavel</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Rodes-Cabau</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Leong</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>van der Kley</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Impact of valvuloarterial impedance on 2-year outcome of patients undergoing transcatheter aortic valve implantation</article-title>. <source>J Am Soc Echocardiogr</source>. <year>2013</year>;<volume>26</volume>: <fpage>691</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.echo.2013.04.003" xlink:type="simple">10.1016/j.echo.2013.04.003</ext-link></comment> <object-id pub-id-type="pmid">23669595</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tamburino</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Capodanno</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Ramondo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Petronio</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Ettori</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Santoro</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis</article-title>. <source>Circulation</source>. <year>2011</year>;<volume>123</volume>: <fpage>299</fpage>–<lpage>308</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCULATIONAHA.110.946533" xlink:type="simple">10.1161/CIRCULATIONAHA.110.946533</ext-link></comment> <object-id pub-id-type="pmid">21220731</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barbanti</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Binder</surname> <given-names>RK</given-names></name>, <name name-style="western"><surname>Dvir</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Freeman</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>CR</given-names></name>, <etal>et al</etal>. <article-title>Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement</article-title>. <source>Catheter Cardiovasc Interv</source>. <year>2014</year>;</mixed-citation></ref>
<ref id="pone.0119817.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moat</surname> <given-names>NE</given-names></name>, <name name-style="western"><surname>Ludman</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>de Belder</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Bridgewater</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Cunningham</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Young</surname> <given-names>CP</given-names></name>, <etal>et al</etal>. <article-title>Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry</article-title>. <source>J Am Coll Cardiol</source>. <year>2011</year>;<volume>58</volume>: <fpage>2130</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2011.08.050" xlink:type="simple">10.1016/j.jacc.2011.08.050</ext-link></comment> <object-id pub-id-type="pmid">22019110</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Seiffert</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Schnabel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Conradi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Diemert</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Schirmer</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Koschyk</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions</article-title>. <source>Catheter Cardiovasc Interv</source>. <year>2013</year>;<volume>82</volume>: <fpage>640</fpage>–<lpage>52</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ccd.24751" xlink:type="simple">10.1002/ccd.24751</ext-link></comment> <object-id pub-id-type="pmid">23172652</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lucon</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Oger</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bedossa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Boulmier</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Verhoye</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Eltchaninoff</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 registry</article-title>. <source>Circ Cardiovasc Interv</source>. <year>2014</year>;<volume>7</volume>: <fpage>240</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCINTERVENTIONS.113.000482" xlink:type="simple">10.1161/CIRCINTERVENTIONS.113.000482</ext-link></comment> <object-id pub-id-type="pmid">24569597</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Heinz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>DeCillia</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Feuchtner</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Mueller</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bartel</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Friedrich</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Relative amplitude index: a new tool for hemodynamic evaluation of periprosthetic regurgitation after transcatheter valve implantation</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2014</year>;<volume>147</volume>: <fpage>1021</fpage>–<lpage>8</lpage>, 9.e1–2. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jtcvs.2013.11.011" xlink:type="simple">10.1016/j.jtcvs.2013.11.011</ext-link></comment> <object-id pub-id-type="pmid">24342900</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Webb</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Altwegg</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Boone</surname> <given-names>RH</given-names></name>, <name name-style="western"><surname>Cheung</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ye</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lichtenstein</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes</article-title>. <source>Circulation</source>. <year>2009</year>;<volume>119</volume>: <fpage>3009</fpage>–<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCULATIONAHA.108.837807" xlink:type="simple">10.1161/CIRCULATIONAHA.108.837807</ext-link></comment> <object-id pub-id-type="pmid">19487594</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nuis</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Dager</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>van der Boon</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Jaimes</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Caicedo</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Fonseca</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Patients with aortic stenosis referred for TAVI: treatment decision, in-hospital outcome and determinants of survival</article-title>. <source>Neth Heart J</source>. <year>2012</year>;<volume>20</volume>: <fpage>16</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s12471-011-0224-z" xlink:type="simple">10.1007/s12471-011-0224-z</ext-link></comment> <object-id pub-id-type="pmid">22167520</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Drews</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Pasic</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Buz</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>d'Ancona</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Dreysse</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kukucka</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Transcatheter aortic valve implantation in very high-risk patients with EuroSCORE of more than 40%</article-title>. <source>Ann Thorac Surg</source>. <year>2013</year>;<volume>95</volume>: <fpage>85</fpage>–<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.athoracsur.2012.08.055" xlink:type="simple">10.1016/j.athoracsur.2012.08.055</ext-link></comment> <object-id pub-id-type="pmid">23141527</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamamoto</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mouillet</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Meguro</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Gilard</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Laskar</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Eltchaninoff</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry</article-title>. <source>Ann Thorac Surg</source>. <year>2014</year>;<volume>97</volume>: <fpage>29</fpage>–<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.athoracsur.2013.07.100" xlink:type="simple">10.1016/j.athoracsur.2013.07.100</ext-link></comment> <object-id pub-id-type="pmid">24140210</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saia</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ciuca</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Taglieri</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Marrozzini</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Savini</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bordoni</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome</article-title>. <source>Int J Cardiol</source>. <year>2013</year>;<volume>168</volume>: <fpage>1034</fpage>–<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijcard.2012.10.029" xlink:type="simple">10.1016/j.ijcard.2012.10.029</ext-link></comment> <object-id pub-id-type="pmid">23164594</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Conrotto</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>D'Ascenzo</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Giordana</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Salizzoni</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tamburino</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tarantini</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Impact of diabetes mellitus on early and midterm outcomes after transcatheter aortic valve implantation (from a multicenter registry)</article-title>. <source>Am J Cardiol</source>. <year>2014</year>;<volume>113</volume>: <fpage>529</fpage>–<lpage>34</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2013.10.025" xlink:type="simple">10.1016/j.amjcard.2013.10.025</ext-link></comment> <object-id pub-id-type="pmid">24315111</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tamburino</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Barbanti</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Capodanno</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Mignosa</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gentile</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Aruta</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Comparison of complications and outcomes to one year of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis</article-title>. <source>Am J Cardiol</source>. <year>2012</year>;<volume>109</volume>: <fpage>1487</fpage>–<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2012.01.364" xlink:type="simple">10.1016/j.amjcard.2012.01.364</ext-link></comment> <object-id pub-id-type="pmid">22356793</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van Belle</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Juthier</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Susen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Vincentelli</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Iung</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Dallongeville</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry</article-title>. <source>Circulation</source>. <year>2014</year>;<volume>129</volume>: <fpage>1415</fpage>–<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002677" xlink:type="simple">10.1161/CIRCULATIONAHA.113.002677</ext-link></comment> <object-id pub-id-type="pmid">24566199</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nguyen</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Babaliaros</surname> <given-names>VC</given-names></name>, <name name-style="western"><surname>Razavi</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Kilgo</surname> <given-names>PD</given-names></name>, <name name-style="western"><surname>Guyton</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Devireddy</surname> <given-names>CM</given-names></name>, <etal>et al</etal>. <article-title>Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2013</year>;<volume>146</volume>: <fpage>1399</fpage>–<lpage>406</lpage>; discussion 13406–7. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jtcvs.2013.07.065" xlink:type="simple">10.1016/j.jtcvs.2013.07.065</ext-link></comment> <object-id pub-id-type="pmid">24075566</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamamoto</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hayashida</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mouillet</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hovasse</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Chevalier</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Oguri</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Prognostic value of chronic kidney disease after transcatheter aortic valve implantation</article-title>. <source>J Am Coll Cardiol</source>. <year>2013</year>;<volume>62</volume>: <fpage>869</fpage>–<lpage>77</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2013.04.057" xlink:type="simple">10.1016/j.jacc.2013.04.057</ext-link></comment> <object-id pub-id-type="pmid">23707321</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lange</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bleiziffer</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mazzitelli</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Elhmidi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Opitz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Krane</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future</article-title>. <source>J Am Coll Cardiol</source>. <year>2012</year>;<volume>59</volume>: <fpage>280</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2011.10.868" xlink:type="simple">10.1016/j.jacc.2011.10.868</ext-link></comment> <object-id pub-id-type="pmid">22196885</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Houthuizen</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Van Garsse</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Poels</surname> <given-names>TT</given-names></name>, <name name-style="western"><surname>de Jaegere</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>van der Boon</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Swinkels</surname> <given-names>BM</given-names></name>, <etal>et al</etal>. <article-title>Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death</article-title>. <source>Circulation</source>. <year>2012</year>;<volume>126</volume>: <fpage>720</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCULATIONAHA.112.101055" xlink:type="simple">10.1161/CIRCULATIONAHA.112.101055</ext-link></comment> <object-id pub-id-type="pmid">22791865</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gotzmann</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Korten</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bojara</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Lindstaedt</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rahlmann</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mugge</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Long-term outcome of patients with moderate and severe prosthetic aortic valve regurgitation after transcatheter aortic valve implantation</article-title>. <source>Am J Cardiol</source>. <year>2012</year>;<volume>110</volume>: <fpage>1500</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2012.07.010" xlink:type="simple">10.1016/j.amjcard.2012.07.010</ext-link></comment> <object-id pub-id-type="pmid">22863177</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Codner</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Assali</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dvir</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Vaknin-Assa</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Porat</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Shapira</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Two-year outcomes for patients with severe symptomatic aortic stenosis treated with transcatheter aortic valve implantation</article-title>. <source>Am J Cardiol</source>. <year>2013</year>;<volume>111</volume>: <fpage>1330</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2013.01.275" xlink:type="simple">10.1016/j.amjcard.2013.01.275</ext-link></comment> <object-id pub-id-type="pmid">23415022</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sabate</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Canovas</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Garcia</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Hernandez Antolin</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Maroto</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Hernandez</surname> <given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: data from the TAVI National Registry 2010–2011</article-title>. <source>Rev Esp Cardiol (Engl Ed)</source>. <year>2013</year>;<volume>66</volume>: <fpage>949</fpage>–<lpage>58</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.rec.2013.07.003" xlink:type="simple">10.1016/j.rec.2013.07.003</ext-link></comment> <object-id pub-id-type="pmid">24774108</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Linke</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wenaweser</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Gerckens</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Tamburino</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bosmans</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bleiziffer</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study</article-title>. <source>Eur Heart J</source>. <year>2014</year>;</mixed-citation></ref>
<ref id="pone.0119817.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Unbehaun</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pasic</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Drews</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Penkalla</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dreysse</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Klein</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Transapical aortic valve implantation: predictors of survival up to 5 years in 730 patients. An update</article-title>. <source>Eur J Cardiothorac Surg</source>. <year>2014</year>;</mixed-citation></ref>
<ref id="pone.0119817.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Le Ven</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Freeman</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Webb</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Clavel</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Wheeler</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Dumont</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement</article-title>. <source>J Am Coll Cardiol</source>. <year>2013</year>;<volume>62</volume>: <fpage>782</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2013.05.044" xlink:type="simple">10.1016/j.jacc.2013.05.044</ext-link></comment> <object-id pub-id-type="pmid">23770162</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rodes-Cabau</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Webb</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Cheung</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ye</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Dumont</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Osten</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience</article-title>. <source>J Am Coll Cardiol</source>. <year>2012</year>;<volume>60</volume>: <fpage>1864</fpage>–<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2012.08.960" xlink:type="simple">10.1016/j.jacc.2012.08.960</ext-link></comment> <object-id pub-id-type="pmid">23062535</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moretti</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>D'Amico</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>D'Ascenzo</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Colaci</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Salizzoni</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tamburino</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Impact on prognosis of periprocedural bleeding after TAVI: mid-term follow-up of a multicenter prospective study</article-title>. <source>J Interv Cardiol</source>. <year>2014</year>;<volume>27</volume>: <fpage>293</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/joic.12115" xlink:type="simple">10.1111/joic.12115</ext-link></comment> <object-id pub-id-type="pmid">24701998</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rau</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wessely</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lange</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Kupatt</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Steinbeck</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Fischereder</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Transcatheter aortic valve implantation in dialysis patients</article-title>. <source>Nephron Clin Pract</source>. <year>2012</year>;<volume>120</volume>: <fpage>c86</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000335781" xlink:type="simple">10.1159/000335781</ext-link></comment> <object-id pub-id-type="pmid">22377618</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>London</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Pannier</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Marchais</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Guerin</surname> <given-names>AP</given-names></name>. <article-title>Calcification of the aortic valve in the dialyzed patient</article-title>. <source>J Am Soc Nephrol</source>. <year>2000</year>;<volume>11</volume>: <fpage>778</fpage>–<lpage>83</lpage>. <object-id pub-id-type="pmid">10752538</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aregger</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Wenaweser</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hellige</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>Kadner</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Carrel</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Windecker</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement</article-title>. <source>Nephrol Dial Transplant</source>. <year>2009</year>;<volume>24</volume>: <fpage>2175</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/ndt/gfp036" xlink:type="simple">10.1093/ndt/gfp036</ext-link></comment> <object-id pub-id-type="pmid">19211648</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Soslau</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Brodsky</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Putatunda</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Parker</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Schwartz</surname> <given-names>AB</given-names></name>. <article-title>Selective reduction of serotonin storage and ATP release in chronic renal failure patients platelets</article-title>. <source>Am J Hematol</source>. <year>1990</year>;<volume>35</volume>: <fpage>171</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">2220759</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gummert</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Bucerius</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Walther</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Doll</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Falk</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Schmitt</surname> <given-names>DV</given-names></name>, <etal>et al</etal>. <article-title>Requirement for renal replacement therapy in patients undergoing cardiac surgery</article-title>. <source>Thorac Cardiovasc Surg</source>. <year>2004</year>;<volume>52</volume>: <fpage>70</fpage>–<lpage>6</lpage>. <object-id pub-id-type="pmid">15103578</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McCullough</surname> <given-names>PA</given-names></name>. <article-title>Contrast-induced acute kidney injury</article-title>. <source>J Am Coll Cardiol</source>. <year>2008</year>;<volume>51</volume>: <fpage>1419</fpage>–<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2007.12.035" xlink:type="simple">10.1016/j.jacc.2007.12.035</ext-link></comment> <object-id pub-id-type="pmid">18402894</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cronin</surname> <given-names>RE</given-names></name>. <article-title>Contrast-induced nephropathy: pathogenesis and prevention</article-title>. <source>Pediatr Nephrol</source>. <year>2010</year>;<volume>25</volume>: <fpage>191</fpage>–<lpage>204</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00467-009-1204-z" xlink:type="simple">10.1007/s00467-009-1204-z</ext-link></comment> <object-id pub-id-type="pmid">19444480</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van Linden</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kempfert</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Rastan</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Holzhey</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Blumenstein</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Schuler</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Risk of acute kidney injury after minimally invasive transapical aortic valve implantation in 270 patients</article-title>. <source>Eur J Cardiothorac Surg</source>. <year>2011</year>;<volume>39</volume>: <fpage>835</fpage>–<lpage>42</lpage>; discussion 42–3. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejcts.2010.11.034" xlink:type="simple">10.1016/j.ejcts.2010.11.034</ext-link></comment> <object-id pub-id-type="pmid">21186126</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamamoto</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hayashida</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mouillet</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Chevalier</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Meguro</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2013</year>;<volume>6</volume>: <fpage>479</fpage>–<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jcin.2013.02.007" xlink:type="simple">10.1016/j.jcin.2013.02.007</ext-link></comment> <object-id pub-id-type="pmid">23702012</object-id></mixed-citation></ref>
<ref id="pone.0119817.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Madershahian</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Scherner</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Liakopoulos</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Rahmanian</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Kuhn</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Hellmich</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Renal impairment and transapical aortic valve implantation: impact of contrast medium dose on kidney function and survival</article-title>. <source>Eur J Cardiothorac Surg</source>. <year>2012</year>;<volume>41</volume>: <fpage>1225</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/ejcts/ezr199" xlink:type="simple">10.1093/ejcts/ezr199</ext-link></comment> <object-id pub-id-type="pmid">22219473</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>